
==== Front
MedComm (2020)
MedComm (2020)
10.1002/(ISSN)2688-2663
MCO2
MedComm
2688-2663
John Wiley and Sons Inc. Hoboken

10.1002/mco2.718
MCO2718
Review
Review
Anoikis in cell fate, physiopathology, and therapeutic interventions
MEI et al.
Mei Jie https://orcid.org/0000-0002-8221-199X
1 2 3 4 5 #
Jiang Xue‐Yao 5 #
Tian Hui‐Xiang https://orcid.org/0009-0007-3632-636X
1 2 3 4 #
Rong Ding‐Chao 1
Song Jia‐Nan 5 6
Wang Luozixian 5 7 8
Chen Yuan‐Shen 1 2 3 4
Wong Raymond C. B. 7 8
Guo Cheng‐Xian 9
Wang Lian‐Sheng 1 2 3 4
Wang Lei‐Yun 10 15974276030@163.com

Wang Peng‐Yuan 5 py.wang@ojlab.ac.cn

Yin Ji‐Ye https://orcid.org/0000-0002-1244-5045
1 2 3 4 yinjiye@csu.edu.cn

1 Department of Clinical Pharmacology Xiangya Hospital, Central South University Changsha Hunan China
2 Institute of Clinical Pharmacology Hunan Key Laboratory of Pharmacogenetics Central South University Changsha Hunan China
3 Engineering Research Center of Applied Technology of Pharmacogenomics Ministry of Education Changsha Hunan China
4 National Clinical Research Center for Geriatric Disorders Xiangya Hospital, Central South University Changsha Hunan China
5 Oujiang Laboratory Key Laboratory of Alzheimer's Disease of Zhejiang Province Institute of Aging Wenzhou Medical University Wenzhou Zhejiang China
6 School of Life Sciences Westlake University Hangzhou Zhejiang China
7 Centre for Eye Research Australia Royal Victorian Eye and Ear Hospital Melbourne Victoria Australia
8 Ophthalmology Department of Surgery The University of Melbourne Melbourne Victoria Australia
9 Center of Clinical Pharmacology the Third Xiangya Hospital Central South University Changsha Hunan China
10 Department of Pharmacy Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei Province China
* Correspondence
Ji‐Ye Yin, Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Email: yinjiye@csu.edu.cn
Peng‐Yuan Wang, Oujiang Laboratory; Key Laboratory of Alzheimer's Disease of Zhejiang Province, Institute of Aging, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Email: py.wang@ojlab.ac.cn
Lei‐Yun Wang, Department of Pharmacy, Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province 430022, China.
Email: 15974276030@163.com

# JieMei, Xue‐Yao Jiang and Hui‐Xiang Tian contributed equally to this work.

15 9 2024
10 2024
5 10 10.1002/mco2.v5.10 e71816 8 2024
28 3 2024
18 8 2024
© 2024 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.
https://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Abstract

The extracellular matrix (ECM) governs a wide spectrum of cellular fate processes, with a particular emphasis on anoikis, an integrin‐dependent form of cell death. Currently, anoikis is defined as an intrinsic apoptosis. In contrast to traditional apoptosis and necroptosis, integrin correlates ECM signaling with intracellular signaling cascades, describing the full process of anoikis. However, anoikis is frequently overlooked in physiological and pathological processes as well as traditional in vitro research models. In this review, we summarized the role of anoikis in physiological and pathological processes, spanning embryonic development, organ development, tissue repair, inflammatory responses, cardiovascular diseases, tumor metastasis, and so on. Similarly, in the realm of stem cell research focused on the functional evolution of cells, anoikis offers a potential solution to various challenges, including in vitro cell culture models, stem cell therapy, cell transplantation, and engineering applications, which are largely based on the regulation of cell fate by anoikis. More importantly, the regulatory mechanisms of anoikis based on molecular processes and ECM signaling will provide new strategies for therapeutic interventions (drug therapy and cell‐based therapy) in disease. In summary, this review provides a systematic elaboration of anoikis, thus shedding light on its future research.

1. Anoikis is an integrin‐dependent form of apoptosis and can affect cell fate.

2. Anoikis widely exists in the physiological and pathological processes of life.

3. Anoikis‐based regulatory strategies are potential targets for therapeutic intervention.

anoikis
cell death
circulating tumor cells
extracellular matrix
integrin
tumor metastasis
National Natural Science Foundation of China 10.13039/501100001809 82373962 82073943 Scientific research project of Furong laboratory of Central South University2023SK2083 Ministry of Science and Technology of China2022YFA1105101 Zhejiang Provincial Natural Science Foundation of ChinaLZ23C070004 National Health and Medical Research Council 10.13039/501100000925 GNT1184076 Natural Science Foundation of Hunan Province 10.13039/501100004735 2021JJ80087 2023JJ30822 Major Research Project for High‐Level Health and Wellness Talents of Hunan ProvinceR2023042 Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South UniversityYX202110 source-schema-version-number2.0
cover-dateOctober 2024
details-of-publishers-convertorConverter:WILEY_ML3GV2_TO_JATSPMC version:6.4.8 mode:remove_FC converted:15.09.2024
Mei J , Jiang X‐Y , Tian H‐X , et al. Anoikis in cell fate, physiopathology, and therapeutic interventions. MedComm. 2024;5 :e718. 10.1002/mco2.718
==== Body
pmc1 INTRODUCTION

In the process of tissue and cell growth and differentiation, the factors that determine cell fate and tissue structure are not only the regulation of internal gene inheritance, but also the external environment. Among them, the extracellular matrix (ECM), which comprises at least a third of tissue structures, take a significant role in the localization, 1 function, 2 and fate of cells. 3 Most of the cells that constitute tissues and organs in living organisms need a specific anchoring environment to survive, 4 which is usually specifically encoded by individual genetic development patterns. 5 If cells fail to maintain proper ECM attachment, anoikis, a programmed autonomously regulated mechanism, is triggered to initiate cell death and thus maintain tissue homeostasis. 6 Anoikis was first discovered in 1994 by disrupting the interaction of normal epithelial cells and ECM. 7 Early researchers believed that anoikis is a programmed cell death triggered by cell detachment from ECM, which avoids distant organ colonization by preventing nonadherent cell growth and improper cell adhesion. 8 , 9 In‐depth research reveals integrin's crucial role in the occurrence of anoikis. 10 Therefore, the Nomenclature Committee on Cell Death defined anoikis as a specific form of intrinsic apoptosis triggered by integrin‐dependent anchorage deficiency. 11

When anoikis occurs, integrin, a heterodimeric transmembrane protein composed of α and β subunits, 12 which is a key dependent component of ECM signaling, not only provides a physical connection to the cytoskeleton, 13 but also transduces ECM signaling to the cell. 13 , 14 Some studies have proved that integrin induces cell anoikis through cell cycle arrest, 15 , 16 cytoskeleton changes, 17 and loss of cell adhesion function. 18 Integrins serve as primary transmembrane receptors for cell adhesion, transmitting mechanical signals and regulating physiological and biochemical behaviors in response to the ECM 19 ; therefore, they are seen as essential members of anoikis. 10 As a family of transmembrane receptors mediating physical and chemical signaling between cells and the ECM, 20 integrins are expressed in a wide range of cells. 21 , 22 Because of its adhesion effect, integrins often have a significant impact on cell anchor‐dependent growth, 23 and therefore regulate cell fate. 24 Extracellular signals include chemical signals, such as monoclonal antibody agents (abciximab, natalizumab, vedolizumab), 25 active proteins (fibronectin, osteopontin), 26 , 27 divalent cations, 28 oxidation environment, 29 as well as physical signals, such as biomechanics (shear stress, stiffness), 30 , 31 magnetic field (radiation), 32 pH, 33 , 34 light, 35 temperature, 36 can disrupt integrin ligation, resulting from impaired cell adhesion adaptability and leading to the occurrence of anoikis.

Based on integrin‐mediated cell adhesion adaptation, external adaptive environmental changes would imply that anoikis has participated in extensive biological processes, such as cell fate (renewal, differentiation, cell death, etc.) 37 and physiopathology (embryonic development, tissue repair, disease occurrence, etc.). 38 In addition, in oncology studies, anoikis has been involved in malignant transformation of tumors, 39 remote colonization of circulating tumor cells (CTCs), 40 regulation of immune environment, 41 response to drug therapy, 42 and prediction and prognosis of diseases. 43 This means that regulatory strategies based on anoikis will be promising targets for disease treatment and interventions, such as regulating anoikis to affect the drug efficacy, 44 tumor metastasis, 45 tumor stemness, 46 and the activity of engineered stem cells. 47 In particular, in stem cell and engineering transformation researches, anoikis poses new challenges to the in vitro and in vivo application of embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs) and other engineering cells. 47 Therefore, this review introduces the research progress of anoikis and its main molecular processes, focusing on its role in cell fate, physiopathological regulation, and emphasizes the potential value of anoikis‐based therapeutic intervention strategies in disease (Figure 1). We also raise the question of anoikis’ in‐depth thinking and new insights into its potential research directions.

FIGURE 1 Extracellular signal regulation and transformation applications of anoikis. Integrin transmits ECM signals including physical and chemical signals to regulate anoikis, thereby regulating cell fate and participating in physiopathological processes of the body, which is of great significance for therapeutic interventions.

2 MOLECULAR PROCESS OF ANOIKIS

Notably, anoikis is defined as a broad and complex regulatory mechanism to specifically refer to a mode of apoptosis induced by ECM alterations in response to extracellular physical or chemical signals. Considering the clear signaling flowthrough involved, anoikis concatenates specific triggers and cascading outcomes, which provides a more comprehensive understanding of how cell respond to extracellular stimuli and how to transfer this stimulus to downstream pathways to induce apoptosis. From the perspective of incoming signals of anoikis, physical stimulus, such as hyperthermia, which affects the integrin cytoskeleton network, have the potential to influence the cell morphology and further leads to anoikis, 48 and shear stress, which modulates integrin β1 adhesion kinase‐mediated multicellular aggregation, thus is able to regulate anoikis resistance. 31 Additionally, chemical signals may also lead to anoikis. For example, an altered fibronectin matrix regulated integrin v‐mediated FAK and ERK phosphorylation, leading to anoikis. 26 Currently anoikis is thought to be mainly mediated by membrane adhesion signaling molecules (integrin family proteins), thus anoikis can respond to both physical and chemical stimuli and may cross‐talk the same downstream signaling pathways via integrin, implying its possible integral role in cell fate regulation, especially cross‐talking physical and chemical signals.

The currently documented integrin family consisted of 18 α subunits and 9 β subunits, 49 as well as the recently reported integrin subunit β‐like 1 (ITGBL1), 50 and different α and β subunits have similar structural characteristics 51 , 52 (Table 1). The interaction between different subunits forms 24 different heterodimers, including the Arg‐Gly‐Asp (RGD)‐binding integrins (αvβ1, αvβ3, αvβ5, αvβ6, αvβ8, α8β1, α5β1, and αIIbβ3), leukocyte adhesion integrins (α4β1, α9β1, αLβ2, αMβ2, αXβ2, αDβ2, α4β7, and αEβ7), collagen‐binding integrins (α1β1, α2β1, α10β1, and α11β1), and laminin‐binding integrins (α3β1, α6β1, α7β1, and α6β4). 53 Although anoikis was reported as a integrin‐dependent pathway, however, the exact mechanisms underlying their interrelationships remain largely unclear 11 (Figure 2). Years ago, anoikis studies focused on individual subunits. For example, the ITGA5, 54 ITGA6, 55 and ITGAV 56 out of the α subunit family were reported to be associated with the anoikis resistance. However, the understanding of mechanisms underlying the interactions between individual integrin subunits and anoikis was challenged by conflicting findings such as the recent report of ITGB5 in promoting anoikis. 57 Meanwhile, investigations into the β subunits found that ITGB4 could inhibit anoikis, 58 ITGB5 promoted anoikis, 47 while ITGB1 59 , 60 and ITGB3 61 , 62 showed a multidirectional regulation of anoikis. Therefore, more and more recent studies started to investigate the function of diverse integrin heterodimers in anoikis. For example, the collagen‐binding integrins (α1β1, α2β1) 63 , 64 and laminin‐binding integrins (α3β1 and α6β4) 65 , 66 show consistent inhibitory effects on anoikis. Interestingly, the RGD‐binding integrin family showed bi‐directional functions, including that αvβ5, 67 αvβ6, 68 and α5β1 65 demonstrate regulatory effects inhibiting anoikis, whereas αvβ3 69 and α8β1 70 have been reported to exhibit promoting effects. However, few correlations between leukocyte adhesion integrin family and anoikis have been reported. Although we have expanded our understanding of the interrelationship between integrins and anoikis by investigating the function of specific heterodimers, however, it seems that their underlying mechanisms were quite complex as there were still some contradictory findings like the αvβ3 may also have an inhibitory role in anoikis. 71 , 72 Therefore, further research is essential to explore the cellular distribution of integrins and the cross‐talk between integrin families. 73 , 74 This exploration holds the potential to contribute to a more nuanced understanding of the intricacies involved in the process of integrin‐mediated anoikis.

TABLE 1 The detail of the integrin subunits.

Gene name	Protein (UniProt)	Structure	Gene name	Protein (UniProt)	Structure	
Integrin α subunit						
ITGA1	Integrin alpha‐1 (P56199)		ITGA2	Integrin alpha‐2 (P17301)		
ITGA2B	Integrin alpha‐IIb (P08514)		ITGA3	Integrin alpha‐3 (P26006)		
ITGA4	Integrin alpha‐4 (P13612)		ITGA5	Integrin alpha‐5 (P08648)		
ITGA6	Integrin alpha‐6 (P23229)		ITGA7	Integrin alpha‐7 (Q13683)		
ITGA8	Integrin alpha‐8 (P53708)		ITGA9	Integrin alpha‐9 (Q13797)		
ITGA10	Integrin alpha‐10 (O75578)		ITGA11	Integrin alpha‐11 (Q9UKX5)		
ITGAD	Integrin alpha‐D (Q13349)		ITGAE	Integrin alpha‐E (P38570)		
ITGAL	Integrin alpha‐L (P20701)		ITGAM	Integrin alpha‐M (P11215)		
ITGAV	Integrin alpha‐V (P06756)		ITGAX	Integrin alpha‐X (P20702)		
Integrin β subunit						
ITGB1	Integrin beta‐1 (P05556)		ITGB2	Integrin beta‐2 (P05107)		
ITGB3	Integrin beta‐3 (P05106)		ITGB4	Integrin beta‐4 (P16144)		
ITGB5	Integrin beta‐5 (P18084)		ITGB6	Integrin beta‐6 (P18564)		
ITGB7	Integrin beta‐7 (P26010)		ITGB8	Integrin beta‐8 (P26012)		
ITGBL1	Integrin beta‐like protein 1 (O95965)					
The structure information of α and β subunits of integrin were obtained from AlphaFold Protein Structure Database (https://alphafold.ebi.ac.uk/)

John Wiley & Sons, Ltd.

FIGURE 2 The regulatory relationship between the integrin family and anoikis. The results and mechanisms of different integrin subunits and their dimers regulating anoikis are different.

In the context of intracellular regulatory processes, downstream of the ECM interactions are the apoptosis mechanisms triggered by the anoikis as feedback of extracellular changes, which can be further divided into intrinsic pathways or extrinsic pathways. Specifically, intrinsic pathways are often associated with cell apoptosis trigged by mitochondrial disturbance, while extrinsic pathways are normally activated by cell death receptors involved in the anoikis. 75 On the one hand, a typical intrinsic pathway downstream of the detachment between the ECM and integrin‐mediated adhesion is the phosphorylation of survival effectors, such as the well‐known FAK and PI3K/Akt pathways. 76 Apoptotic protein family members, such as BCL‐2, can be suppressed by the FAK phosphorylation, promoting the activation of apoptotic Bax and Bak, which can move from cytoplasmic ectopia to mitochondrial outer membrane to form oligomers, causing mitochondrial membrane permeability and cytochrome c release through the formation of small pores. 77 Meanwhile, the phosphorylated FAK pathway suppresses the activity of its downstream PI3K/Akt pathway, resulting in the release of cytochrome c, caspase‐9, and the auxin apoptotic activator to form an “apoptotic body (disc)” that activates the downstream caspase‐3 to perform the apoptotic process. 78 On the other hand, extrinsic pathways recruit cell death receptors, including the Fas receptor, and the tumor necrosis factor‐α, to activate cell apoptosis. 79 For example, the Fas receptor forms the death inducible signal complex (disc) with its ligand FasL, recruiting the caspase‐3, ‐6, and ‐7 for cell apoptosis. 80 The activation of the extrinsic pathways may follow some types of mitochondrial damages, implying the potential cross‐talk between the intrinsic and extrinsic pathways induced by the anoikis. 81 In summary, the anoikis information flow starts from the ECM changes induced by physical or chemical signals, though the role of integrins in transferring these signals was largely unclear, end in the activation of cell apoptosis pathways which majorly rely on intrinsic mitochondrial disturbance or cell apoptosis processes mediated by the activation of the extrinsic cell death receptors. Therefore, the anoikis plays a significant role in cell fate regulation and recruits a large number of molecules which play different roles in different life activities to respond to extracellular changes.

3 ANOIKIS IN CELL FATE

To explore the role of anoikis in cell fate, researchers focused on the role of integrin‐mediated ECM signaling regulation mechanism of anoikis in in vitro research models. Currently, many in vitro models, such as cell models, organoid models, and animal models, were developed to simulate the original cell fate process and physiological environment, providing convincing and comprehensive evidence for pathology and pharmacology discoveries. 82 For example, tumor research has been boosted by the establishment of human tumor cell lines in vitro, starting from the first cultured HeLa cells 83 in 1950s to primary cells, 84 and more recent engineered cells. 85 However, how these ECM alterations or in vitro environment changes affect or promote the establishment of in vitro models was largely debated. The potential of anoikis in responding to ECM changes suggests that its role in these models may largely overlooked currently.

3.1 Anoikis in cell culture

The traditional 2D model used to dominate the realm of in vitro culture for a long time. 86 , 87 Presently, common vessels for 2D adherent cell culture encompass flat polymethylmethacrylate coatings, cell culture glass slides, and tissue culture plates (TCPs), among others. However, an interesting truthy is that even the same type of cells often behaves differently, such as performing distinct growth phenotypes, when culture on different material surfaces. 88 This means that different cell contact surfaces, or cell culture planes, have an impact on cell growth and life processes. In other words, the way that cells respond differently to adhesion of culture surfaces thereby resulting in different cell fates. 89 , 90 For example, to address the in vitro survival of primary intestinal epithelial cells, collagen‐ordered membrane schemes were designed to increase the survival of intestinal cells and helped to maintain their function. 91 As an anchorage‐dependent mode of programmed death regulated by ECM signaling, 92 anoikis is often directly involved in culture planes‐mediated cell fate processes. Years ago, researchers have found on some nonintegrin‐recognizable matrices, such as poly(N‐p‐vinylbenzyl‐4‐O‐beta‐d‐galactopyranosyl‐d‐gluconamide) and poly‐l‐lysine, that hepatocytes (adherent‐dependent cells) developed anoikis in response to ECM disruption. 93 In addition, silicon‐substituted hydroxyapatites, a class of biomaterials different from traditional two‐dimensional cultures materials, have been reported to induce cell anoikis by affecting the signaling at the interface between cells and biomaterials and altering cell adhesion, which helped to delay osteoblast differentiation and had potential applications for therapies such as osteoporosis. 94 On the contrary, collagen coatings of interconnected macroporous nanometric carbonated hydroxyapatite/agarose scaffolds were proved to have an inhibitory effect on anoikis, 95 implying that by influencing the interaction of cell culture planes with cells could be one of the means to modulate the cell fate of anoikis.

In 3D cell culture, it is considered to be a more appropriate way to regulate cell fate for in vitro cell modeling. A recent study compared the melanoma cells cultured in 2D and 3D environments, revealing substantial changes in cell adhesion‐related signaling pathways and anoikis resistance related gene expressions. 96 This means that unlike the traditional 2D culture modes, 3D culture will bring about new microscopic changes to the cell culture modes. At present, more 3D culture approaches, including spheroids, 97 , 98 organoids, 99 microcarriers, 100 and microgravity, 101 have altered cell fate to some extent, especially the regulation of anoikis. With respect to the classical ovarian cancer metastasis models, it has been clarified that tumor cells formed 3D structures such as spheroids in order to survive in the nonadherent state to resist anoikis and thus gained the survival power for distal metastasis, 102 , 103 in which integrin αvß3‐mediated cell adhesion process may be the key mechanism of anoikis resistance. 104 Thus, some derived nonadherent or ultra‐low adhesion 3D culture modes are widely used in sphere formation assay, assessment of tumor malignancy or stemness due to their unique anchoring‐independent growth or anoikis resistance. 105 Moreover, researchers have long found that the contact surface between the cells and the culture system requires a certain connection or else there will be attrition of the cells. 106 Therefore, the injectable cell‐laden microcarriers, a class of suspensions in hydrogels, were developed to help the cells to undergo adhesive growth thereby avoiding anchorage‐dependent cell death, which had a positive significance in addressing cell loss during osteogenic differentiation of mesenchymal stem cells (as representative anchorage‐dependent cells). 107 And it was found that the microcarriers can help the cellular integrins and extracellular ligands to connect to achieve stable anchorage‐dependent cell growth, which is largely attributed to the promotion of anoikis resistance.

With the establishment of common understandings about the influence of the ECM alterations on cell fate, more and more studies started to consider the interactions between cells and its microenvironments, which in turn to help directing novel culture techniques to mimic a in vivo microenvironment to promote cell culture better. 108 , 109 It also enhances our comprehension of intricate cell–cell and cell–matrix interactions, ultimately paving the way for the establishment of more advanced research systems. As a result, subsequent strategies, including suspension culture, 110 , 111 coculture methodologies, 112 3D cultivation, 113 specialized biomaterial‐based cultivation, 88 , 114 and in vivo culture systems, 115 were developed towards creating more suitable ECM conditions to realize more precise regulation of cell fate during in vitro cell culture.

However, it is widely accepted that current preclinical models, especially in vitro cell models, are hard to accurately replicate the in vivo cellular microenvironment, biological intricacies and biophysical factors, leading to the potential impacts on drug sensitivity testing. By contrast, 3D cultivation systems were thought to be a better mimic of in vivo conditions, which enhances their sensitivity in drug screening. 116 This phenomenon may be attributed to adopting rounded morphologies and forming small hemispherical plasma membrane protrusions of cells to promote the creation of signaling hubs proximal to the plasma membrane, which often leads to anoikis resistance that facilitates a better survival rate facing ECM alterations. 117 Given the pivotal role of anoikis resistance in tumor migration and metastasis, and recognizing that cell aggregation is an important mechanism for conferring anoikis resistance, 118 material scientists developed a similar in vitro platform by modifying TCPs to create a fluoro‐silica surface to finely regulate cell aggregation–disaggregation events, further enhancing our comprehension of intricate cell–cell and cell–matrix interactions. 119

In summary, learned from the development of cell culture systems, it is essential to highlight that factors including genetic regulations, chemical interventions, and physical environmental stimulus, could fundamentally lead to different cell fate, and in particular, different response mechanisms to anoikis. Therefore, considering the key role of anoikis in responding to these factors, mechanisms underlying anoikis resistance have the potential to direct novel strategies for in vitro cell culture. However, the optimal ECM culture environments vary a lot for various cell types, leading to the difficulty in determining a universal system to facilitate the appropriate physiological reflections of various cell fate in vivo. In summary, knowledge about anoikis is the powerful tool for developing promising cell culture systems to simulate in vivo conditions as much as possible.

3.2 Anoikis in engineering applications for stem cells

However, for engineered cells such as iPSCs, the focus is not on simulating the state and characteristics of cells in vivo, but on exploring new directions for cell function. 120 Certainly, engineering cells including ESCs, 121 mesenchymal stem cells, 122 hematopoietic stem cells, 123 , 124 and neural stem cells 125 , 126 are not excluded as suitable tools for simulating cell lines in vivo. Importantly, as vital models for studying cell fate and unknown functions, they eliminate the challenges of exploring the primitive ECM. Then, the research on the cell death mechanism including anoikis and its engineering transformation value will be purer.

Since their derivation, stem cells such as human embryonic stem cells (hESCs) have been used in various studies, including developmental biology, pathology, and genomics. 127 , 128 However, hESCs are subjected to constant anoikis in cell culture, 129 as evidenced by the fact that one of the main difficulties in hESCs culture is that they are particularly sensitive to dissociation, which is precisely the operative process underlying cell culture in vitro. 130 Considering that hESCs is highly susceptible to cell death after dissociation into single cells, researchers have long believed that cell adhesion signal perception and anoikis caused by cell detachment may be important incentives. 131 In stem cell‐derived cell lines, such as hESCs‐derived retinal pigment epithelial (hESC‐RPE), it is also widely found that ECM detachment, serum deprivation, hydrogen peroxide stimulation can induce anoikis, which undoubtedly restricts the research of such stem cells in the pathogenesis of age‐related macular degeneration, stem cell therapy in vivo, and other fields. 132

On the other hand, the cryopreservation of hESCs still have the problems of low recovery rate and loss of pluripotency after thawing. 133 Although the transcriptome data of the cells after thawing showed relative stability, the expression of genes related to cell morphology, death, regeneration, and differentiation has changed. Researchers have pointed out that anoikis is a promising target for improving the survival rate and maintaining pluripotency of hESCs after cryopreservation. 133 As a promising source of cell therapy for retinal degenerative diseases, hESC‐RPE is also facing the same issues of timeliness and functionality of cryopreservation. It has been found that hESC‐RPE cryopreserved at passage 2 day 5 tends to maintain a certain high quality of cell viability and adhesion. 134 As for human iPSC (hiPSC), which is the most promising stem cell therapy, researchers have begun to pay attention to the effect of cryopreservation on the activity of hiPSC. 135 hiPSC‐derived retinal pigment epithelium (hiPSC‐RPE) cells have been explored the effects of cell activity and metabolic functions at different freezing temperatures and was found that cell viability is correlated with preservation time and temperature, with the best cell status at 16°C and a significant reduction in anoikis. 136 Therefore, for stem cell research, simple and efficient cryopreservation methods are urgently needed to maintain cell activity and function. The mechanism by which temperature affects cell cryopreservation and resuscitation activity is poorly understood and may involve alterations in cell matrix adhesion and secretory protein activity due to changes in the elastic modulus of the ECM. 137 But as an anoikis‐dependent pathway, the role of integrin signaling in hESCs maintenance is highly promising.

Stem cells such as iPSCs are also continuously affected by anoikis in culture, 129 which are also prone to anoikis after single cell dissociation. 138 And anoikis serves as the primary factor contributing to low survival rates following transplantation and represents a significant hurdle in the field of stem cell therapy. 139 , 140 Cell therapy based on neural stem cells is faced with the problem of cell transplantation‐related survival and fate regulation. Most of the implanted cells will die due to oxidative stress, anoikis and other factors within few days after transplantation. Interestingly, cell aggregates, such as neurospheres, can prevent anoikis and increase cell viability by providing a special extracellular support environment, and the effect of colony sphere size on this process is important. 141 Mesenchymal stem cells with multilineage differentiation ability also showed sensitivity to ECM adhesion. It has been reported that miR‐125b, an adhesion‐regulated microRNA, can protect mesenchymal stem cells from anoikis. 47 In addition, regulation of ITGA5B1 expression can also increase the cell adhesion, cell viability of bone marrow mesenchymal stem cells by inhibiting cell anoikis, 142 which is of great reference significance for stem cell therapy. Anoikis is also a rate‐limiting factor in the formation of cardiomyocytes in the heart transplantation therapy of hESC‐derived cardiomyocytes (hESC‐CMs). 143 Currently, some superior therapies for cotransplantation of biocompatible materials with hESC‐CMs and promoting heart regeneration have been reported. This may be the result of providing unique ECM support to overcome anoikis. 144

As a process in which cells sense extracellular signals and directly transmitted intracellular regulation of cell death fate, anoikis undoubtedly proposes a potential direction for the culture and research transformation of engineering cells. The integrin‐dependent mechanism based on anoikis implies that integrin, as a cell adhesion and extracellular mechanoreceptor, 145 is an important anoikis regulatory pathway. Integrin can sense the mechanical force generated by the matrix, thereby converting these stimuli into downstream signals that regulate cell viability. 146 Therefore, anoikis will be regulated when engineering cells perform extracellular signal regulation, including physical and mechanical, chemical, and other signal stimulation. For example, molecular inhibitors, special petri dish surface topologies and some biological culture materials influenced the cell survival by affecting integrin on the cell surface. 59 , 93 , 147 This is certainly a promising direction for researchers wishing to study the efficient culture of stem cells in vitro, iPSC differentiation, stem cell transplantation, stem cell therapy, and other engineering applications (Figure 3).

FIGURE 3 Engineering applications of anoikis. Conventional cell in vitro culture systems, including primary cell extraction, culture, proliferation, passage, cryopreservation, recovery, and heredity, continue to be blocked by anoikis. Physical, chemical, and biological regulatory processes based on ECM can regulate cell fate by affecting integrin, which is of great value for stem cell‐based differentiation, transplantation, stem cell therapy, and other engineering applications.

4 ANOIKIS IN PHYSIOPATHOLOGY

Cell death serves as the ultimate fate of cells, representing not merely an endpoint, but rather a protracted process. 148 Similarly, when cells encounter an unsuitable ECM environment, their surface integrin‐mediated connections are disrupted, inciting the activation of anoikis signals, following a long cascade to regulate physiological activities of cells in respond to the disruptions. 149 Accompanied by the cell self‐rescue mechanism, an intricate cellular fate‐regulating process ensues within the extensive cell populations, influencing the overarching biological functions of the organism as a whole. Consequently, anoikis functions not only as a regulator of cellular fate, but also as a vital driver for the sustenance of individual life (Figure 4).

FIGURE 4 Anoikis are involved throughout the life. Anoikis is involved in the process from implantation of the fertilized egg to embryonic development, tissues and organs development, homeostasis maintenance, pathological processes, and body aging. CTCs, circulating tumor cells.

4.1 Anoikis in physiology

Life begins from the implantation of the fertilized egg in the uterus. 150 During the beginning stage after implantation, the fertilized egg need to adapt the diverse ECM in the uterus to start cell division and differentiation, and quickly establish the embryonic development. 151 , 152 Studies have shown that stratified epithelial budding, as the first step of branching morphogenesis in embryonic organs undergoing a critical stage of epithelial morphogenesis, is driven by an overall combination of strong cell–matrix adhesion and weak cell–cell adhesion of peripheral epithelial cells. And in‐depth studies have found that β1‐integrin‐mediated cell–matrix adhesion was required for successful budding, 153 implying that integrin‐mediated cell adhesion and anoikis have been involved in the physiological processes of life since early embryonic life. Later on, the fetus undergoes a phase of rapid growth and accelerated metabolism before the age of one, 154 bringing the challenge about overcoming dynamical ECMs and continue growing robustly. Especially, how these dynamically changing cells, such as neurons, bone, and muscle cells, overcome the challenges posed by an unsuitable ECM and continue to grow robustly remains a question that requires further exploration. 155 , 156 For example, millions of neural progenitor cells undergo cell divisions and delamination to differentiate into specific functional regions during brain development, in which anoikis plays a crucial role in distinguishing the difference between the pathological detachment of progenitor cells and the normal delamination of daughter neuroblasts. 157 Therefore, mechanisms involved in cells sensing and responding to the ECM changes, such as the anoikis, are important in promoting the organisms’ proper formation and growth.

In the maintenance of tissue homeostasis and functional repair, it is proved that anoikis was involved in the clearance of lumens in developing mammary glands 158 and the involution of lactating mammary glands. 159 Moreover, anoikis within luminal cells in the prostate epithelium occurs in conjunction with tissue repair programs during inflammatory damage and epithelial cell death processes caused by bacterial or viral infections. 160 Considering the widely recognized notion that cell renewal occurs throughout the lifespan and cell signaling is influenced by the ECM and integrins, 161 anoikis is considered to participate in the self‐renewal process of cellular life, as well as the body's inflammation and immune response processes, 162 which in turn, maintains organism homeostasis and regulates tissue repair. However, in these life processes involving in anoikis, the role of ECM receptors and integrin response mechanisms has not yet been clearly reported and requires more attention in future researches. 163

4.2 Anoikis in pathology

Anoikis is widely involved in pathological processes stimulated by external environmental interventions, particularly in the context of vascular function, nerve damage, tissue fibrosis, diabetes, fatty liver, tumor development, and CTCs metastasis. 164 , 165 , 166 , 167 , 168 It is reported that the loss of functional contact with integrins can activate anoikis and impair vascular development, leading to chronic vascular diseases in diabetes, which is a major cause of mortality in diabetic patients. 169 Anoikis is also implicated in the pathological remodeling of cardiovascular tissues, including detachment of cardiomyocytes in heart failure, endothelial denudation and plaque rupture in atherosclerosis, as well as smooth muscle cell loss in arterial aneurysms and varicose veins. 142 , 144 , 170 Sater et al. 171 have summarized the literature and concluded that anoikis hindered the recovery process of traumatic brain injury, exacerbated brain damage, and impaired synaptic plasticity and other central nervous system functions. However, the endocannabinoid‐metabolizing enzyme abhydrolase domain‐containing 4 has been shown to mediate anoikis specifically to protect the embryonic brain from the consequences of sporadic delamination errors and teratogenic insults. 157 In the pathway regulating anoikis through integrins, arginine methylation of integrin alpha‐4 can prevent the development of fibrosis in alcohol‐related liver disease. 172 The loss of osteocyte β3 integrin leads to abnormal cell morphology, as well as reduced bone mass and compromised biomechanical properties in weight‐bearing long bones of adult mice. 173

Anoikis also plays a critical role in tumorigenesis and malignant transformation. 174 , 175 Therefore, it represents an important research focus with implications for drug treatment response, patient prognosis, and early cancer screening. Zhou and his colleagues 176 found that the stabilization of XIAP (X‐linked inhibitor of apoptosis protein) by USP11 (an effective oncogenic factor) suppressed anoikis, promoting cancer development in breast epithelial cells, and increasing drug resistance in breast cancer cells. Similarly, inhibiting DOK2, a tumor suppressor in lung cancer, led to anoikis suppression and carboplatin resistance in ovarian cancer cells. 177 However, whole‐genome sequencing analysis in gastric cancer proved that RHOA mutation in diffuse‐type tumors promoted anoikis escape, and the most disturbed pathway in gastric cancer happens to be adherens junction and focal adhesion. RHOA is a key participant, suggesting that anoikis maybe a promising target during the pathological process of the gastric cancer. 178 Many studies also have identified anoikis‐related genes and established models that effectively predict the prognosis and immune landscape of various cancers, including ovarian serous cystadenocarcinoma, 179 cutaneous melanoma, 180 malignant pleural mesothelioma, 181 and neuroblastoma. 162

Appropriate ECM adhesion served as a barrier to tumor cell migration, 182 and resistance to anoikis is often a necessary ongoing process in tumor metastasis (Figure 5). It is involved in the metastasis mechanisms of various cancer, including colorectal cancer, 183 gastric cancer, 184 prostate cancer, 185 ovarian cancer, 59 and breast cancer. 186 It was reported that MYH9 can regulate CTNNB1 expression to induce anoikis resistance, promoting gastric cancer metastasis. 184 CPT1A promoted anoikis resistance in esophageal squamous cell carcinoma 187 and colorectal cancer 183 via redox homeostasis, thereby facilitating distant metastasis. Mesenchymal stem cell‐derived IL‐8 could induce CXCR1/AKT signaling activation, thereby promoting anoikis resistance and pulmonary metastasis of osteosarcoma cells. 188 Overcoming ECM nonpermissiveness and anoikis is often the first step for CTCs, 189 which disseminate from the primary site through blood and lymphatic circulation, undergo processes of primary site detachment, entry into the bloodstream and lymphatic system, distant colonization, and survival. 118 Interestingly, some studies have shown that microorganisms play a role in facilitating CTC metastasis. 190 However, it remains unclear whether these microorganisms play a role in shaping CTC resistance against ECM detachment or if anoikis is involved in these mechanisms. Another representative event of tumor metastasis involving anoikis is the theory of peritoneal metastasis in epithelial ovarian cancer. 191 , 192 It is well known that ovarian cancer, especially high‐grade serous ovarian cancer (HGSOC), is accompanied by severe ascites, 193 and one of the important theoretical hypotheses is that the tumor cells spread to the peritoneal cavity, which in turn acquires a stronger malignancy and proliferation capacity. 194 , 195 The survival of epithelial cells of tubal origin in the peritoneal cavity through the ovary has not been clearly explained. 196 Anoikis has been identified as a driver of HGSOC metastasis. For example, CBX2 has been reported to promote the progression, metastasis, and chemoresistance of HGSOC through anoikis resistance. 197 In addition, other pathways including Notch signaling pathway and autophagy regulator ULK1 have been identified as genetic features of anoikis escape in ovarian cancer cells. 198 Gao's finding clearly articulated its mechanism by which HGSOC ascitic tumor cells characterized by integrin α5high readily formed heterotypic spheroids with fibroblasts, which is associated with anoikis resistance in the ascites setting, ultimately both greatly contributed to its metastasis and early peritoneal spread. 199 , 200 Recent studies have recognized anoikis‐associated features as promising tools for assessing prognosis and predicting response to treatment of ovarian cancer. 201 , 202 Therefore, further attention and investigation in future research are warranted to shed light on these processes.

FIGURE 5 Anoikis is a necessary and ongoing barrier to tumor metastasis (CTC distant metastasis). During the process of tumor cells escaping from primary tumor and entering the blood, anoikis occurs continuously. Only the CTCs that maintains anoikis resistance can complete distant metastasis and colonization.

5 ANOIKIS IN THERAPEUTIC INTERVENTIONS

As mentioned above, the extensive roles of anoikis in individual cell fate and even in the physiopathology of the organism have been recognized, thus whether anoikis‐based regulatory are promising strategies for therapeutic interventions has attracted extensive research. Indeed, a number of studies have focused on the potential benefits of anoikis regulation for disease treatment, 203 , 204 and some studies on the mechanisms of anoikis regulation are being exploring, 204 , 205 which are potential directions for therapeutic intervention (Figure 6).

FIGURE 6 Anoikis in therapeutic interventions. Some regulatory drugs based on anoikis and integrins show potential to intervene in drug therapy and cell‐based therapy, which is helpful in overcoming disease progression, tumor metastasis, drug resistance, and stem cell survival issues. Additionally, there are several molecular pathways, noncoding RNAs, epigenetic modifications, and ECM regulation processes that can affect anoikis, which are potential intervention strategies for anoikis. ECM, extracellular matrix.

5.1 Intervention strategy of anoikis

Currently, anoikis is becoming a hallmark of cancer metastasis, so regulatory strategy based on anoikis resistance are extremely valuable in tumor research. 206 NF‐kB, 207 PI3K/Akt, 208 , 209 STAT3, 210 PKC, 211 TrkB, 212 Notch, 213 AMPK, 214 MAPK, 63 Wnt, 215 and Hippo 216 were proved to promote anoikis resistance. In addition, some non‐coding RNAs have been reported to be involved in the molecular process of anoikis. 185 , 217 , 218 , 219 Some epigenetic modification processes have also been suggested as possible anoikis regulatory strategies, including ubiquitination, 220 , 221 O‐glycosylation, 222 , 223 histone deacetylation, 224 methylation, 225 , 226 RNA N6‐methyladenosine, 227 and so on. It is worth mentioning that ECM regulation is also a possible direction, including ECM alterations, 228 tumor microenvironment, 229 redox homeostasis, 230 cellular mechanosensation, 31 , 231 adhesion sensing, 189 and colony formation 118 processes, which are effective targets for the regulation of anoikis.

There is also a potential intervention strategy based on the integrin‐dependent mechanism of anoikis. Since integrins are required for ECM signaling to the cell, this means that integrins are naturally targets for the regulation of anoikis. 25 As of June 2024, there have been over 140 clinical trials on integrins (https://www.clinicaltrials.gov/, https://www.clinicaltrialsregister.eu/, and http://www.chictr.org.cn using the search term “integrin”). Among them, the main chemotype of agents are small molecule, biologic (humanized mAb, antigen‐binding fragment), peptide, and so on, mainly targeting αLβ2, α4β7, α4β1, αIIbβ3, αvβ1, αvβ3, αvβ6, α5β1, αvβ8, αvβ5, α10β1, and αEβ7 dimers (Table 2). There are eight drugs targeting integrins have been marketed, but only Carotegrast is administered orally, 232 while Efalizumab was withdrawn from the market in 2009 due to an increased risk of progressive multifocal leukoencephalopathy. 233 These marketed drugs target the four integrins αIIbβ3, α4β7, α4β1 and αLβ2. 25 , 53 These clinical trials are suggesting the potential of integrin‐based regulatory for application in therapeutic interventions of disease, and likewise imply that integrin‐based regulatory strategies for anoikis may influence cell fate and thus the direction of disease therapy.

TABLE 2 Therapeutics based on integrin heterodimers.

Targeted integrins	Agents (chemotype)	Indication	Clinical trial number (study status)	Structure of integrin heterodimers	
αLβ2	Lifitegrast (small molecule)a	Dry eye disease	NCT03686878 (completed), NCT03451396 (completed), NCT01636206 (completed)		
Efalizumab (mAb)b	Plaque psoriasis	NCT00097240 (completed), NCT01079988 (completed), NCT00109252 (completed)	
7HP349 (small molecule)	Solid tumors	NCT04508179 (completed)	
αIIbβ3	Tirofiban (small molecule)a	Acute coronary syndrome and thrombotic cardiovascular events	NCT01498003 (completed), NCT00566891 (completed), NCT00790387 (completed)		
Eptifibatide (small molecule)a	Acute coronary syndrome and thrombotic cardiovascular events	NCT01919723 (completed), NCT02925923 (completed), NCT00111566 (completed)	
Abciximab (antigen‐binding fragment)a	Acute coronary syndrome and thrombotic cardiovascular events	NCT00379418 (completed), NCT00169819 (completed), NCT00271401 (completed)	
α4β7	Vedolizumab (mAb)a	Ulcerative colitis and Crohn's disease	NCT02788175 (completed), NCT05281614 (completed), NCT02862132 (completed)		
Natalizumab (mAb)a	Multiple sclerosis and Crohn's disease	NCT00744679 (completed), NCT01884935 (completed), NCT00536120 (completed)	
Carotegrast (small molecule)a	Moderate ulcerative colitis	Not available	
PN‐943 (peptide)	Ulcerative colitis	NCT04504383 (completed)	
MORF‐057 (small molecule)	Healthy volunteers	NCT04580745 (completed)	
Etrolizumab (mAb)	Crohn disease	NCT02394028 (completed)	
Firategrast/SB‐683699 (small molecule)	Multiple sclerosis	NCT00395317 (completed)	
α4β1	Natalizumab (mAb)a	Multiple sclerosis and Crohn's disease	NCT00744679 (completed), NCT01884935 (completed), NCT00536120 (completed)		
Carotegrast (small molecule)a	Moderate ulcerative colitis	Not available	
7HP349 (small molecule)	Solid tumors	NCT04508179 (completed)	
Firategrast/SB‐683699 (small molecule)	Multiple sclerosis	NCT00395317 (completed)	
α5β1	JSM‐6427 (small molecule)	Age‐related macular degeneration	NCT00536016 (completed)		
AXT107 (peptide)	Diabetic macular edema	NCT04697758 (terminated)	
Age‐related macular degeneration	NCT04746963 (terminated)	
Volociximab (mAb)	Age‐related macular degeneration	NCT00782093 (completed)	
Melanoma	NCT00099970 (completed)	
Pancreatic cancer	NCT00401570 (completed)	
PF‐04605412 (mAb)	Nonhematologic malignancies	NCT00915278 (terminated)	
Plasmid AMEP (gene therapy)	Melanoma	2011‐005538‐20 (prematurely ended)	
αvβ5	Intetumumab (mAb)	Prostatic neoplasms	NCT00537381 (completed)		
Solid tumors	NCT00888043 (completed)	
Melanoma	NCT00246012 (completed)	
Abituzumab (mAb)	Colorectal and ovarian cancer patients with liver metastases	NCT00848510 (completed)	
Prostate cancer	NCT00958477 (completed), NCT01360840 (completed)	
αvβ6	IDL‐2965 (small molecule)	Idiopathic pulmonary fibrosis and nonalcoholic steatohepatitis	NCT03949530 (terminated)		
PLN‐74809 (small molecule)	Idiopathic pulmonary fibrosis	NCT04072315 (completed), NCT04396756 (completed)	
	Primary sclerosing cholangitis	NCT04480840 (completed)	
JSM‐6427 (small molecule)	Age‐related macular degeneration	NCT00536016 (completed)	
Intetumumab (mAb)	Prostatic neoplasms	NCT00537381 (completed)	
	Solid tumors	NCT00888043 (completed)	
	Melanoma	NCT00246012 (completed)	
Abituzumab (mAb)	Colorectal and ovarian cancer patients with liver metastases	NCT00848510 (completed)	
	Prostate cancer	NCT00958477 (completed), NCT01360840 (completed)	
αEβ7	Etrolizumab (mAb)	Crohn disease	NCT02394028 (completed)		
α10β1	XSTEM‐VLU (Cell‐based therapy)	Venous leg ulcer	NCT05549609 (recruiting)		
αvβ1	IDL‐2965 (small molecule)	Idiopathic pulmonary fibrosis and nonalcoholic steatohepatitis	NCT03949530 (terminated)		
PLN‐74809 (small molecule)	Idiopathic pulmonary fibrosis	NCT04072315 (completed), NCT04396756 (completed)	
	Primary sclerosing cholangitis	NCT04480840 (completed)	
PLN‐1474 (small molecule)	End‐stage liver fibrosis in nonalcoholic steatohepatitis	Not available	
Intetumumab (mAb)	Prostatic neoplasms	NCT00537381 (completed)	
	Solid tumors	NCT00888043 (completed)	
	Melanoma	NCT00246012 (completed)	
	Abituzumab (mAb)	Colorectal and ovarian cancer patients with liver metastases	NCT00848510 (completed)		
		Prostate cancer	NCT00958477 (completed), NCT01360840 (completed)		
αvβ8	JSM‐6427 (small molecule)	Age‐related macular degeneration	NCT00536016 (completed)		
Abituzumab (mAb)	Colorectal and ovarian cancer patients with liver metastases	NCT00848510 (completed)	
	Prostate cancer	NCT00958477 (completed), NCT01360840 (completed)	
αvβ3	IDL‐2965 (small molecule)	Idiopathic pulmonary fibrosis and nonalcoholic steatohepatitis	NCT03949530 (terminated)		
ProAgio (peptide)	Pancreatic cancer and solid tumor malignancies	NCT05085548 (recruiting)	
	Pancreatic ductal adenocarcinoma	NCT06182072 (recruiting)	
AXT107 (peptide)	Diabetic macular edema	NCT04697758 (terminated)	
	Age‐related macular degeneration	NCT04746963 (terminated)	
Etaracizumab/MEDI522 (mAb)	Colorectal cancer or other solid tumors	NCT00284817 (completed)	
	Plaque psoriasis	NCT00192517 (completed)	
	Rheumatoid arthritis	NCT00069017 (completed)	
Intetumumab (mAb)	Prostatic neoplasms	NCT00537381 (completed)	
	Solid tumors	NCT00888043 (completed)	
	Melanoma	NCT00246012 (completed)	
Plasmid AMEP (gene therapy)	Melanoma	2011‐005538‐20 (prematurely ended)	
Abituzumab (mAb)	Colorectal cancer	NCT01008475 (completed)	
	Solid tumor	NCT01327313 (completed)	
	Colorectal and ovarian cancer patients with liver metastases	NCT00848510 (completed)	
Superscript “a” refers to the marketed drugs, and “b” refers to the drug that have been marketed but withdrawn in 2009. The clinical trials of integrins were obtained from ClinicalTrials.gov (https://www.clinicaltrials.gov/) and EudraCT (https://www.clinicaltrialsregister.eu/ctr‐search). AlphaFold 3 234 (https://golgi.sandbox.google.com/) predicted the structure of integrin heterodimers.

John Wiley & Sons, Ltd.

In summary, anoikis, as an integral aspect of cell fate, significantly influences the physicochemical sensation of cells. Consequently, alterations happened in the anoikis process can affect the effectiveness of various therapeutic strategies in the clinic. Targeting anoikis through molecular regulation and ECM signaling offers promising approaches to overcoming therapeutic resistance and guides the development of more effective targeted therapies for diseases.

5.2 Anoikis and drug development

Anoikis, as a type of apoptosis influenced by the ECM, is not only a risk factor for the development, progression, and metastasis of many diseases, 9 , 235 but also contributes to drug or therapeutic resistance. 40 Therefore, a detailed understanding of the molecular pathways and regulatory mechanisms of anoikis is essential for designing effective targeted therapeutic strategies and addressing drug resistance.

Tajbakhsh et al. 236 have argued that anoikis resistance is responsible for tumor development, therefore drug development based on anoikis‐related molecular pathways are extremely important for the treatment of triple‐negative breast cancer. These include DSF, nanoencapsulated doxorubicin, berberine, salinomycin, tubeimoside V, 5‐azacytidine, synthesized flavonoid derivative GL‐V9 and HPW‐RX40, and other compounds have been recognized as potential agents for regulating anoikis resistance in breast cancer cells. 236 In studies of HGSOC precancerous lesions, norepinephrine has been found to instigate anchorage independence and micrometastasis of preneoplastic lesions from the fallopian tube epithelium to the ovary, which is largely accomplished through β‐adrenergic receptor‐dependent anoikis resistance, and the use of the β‐adrenergic receptor blocker propranolol eliminates the globule formation and cell viability conferred by norepinephrine. 237

On the other hand, the effects of ECM alterations on cell fate as well as drug sensitivity have long been of interest in in vitro studies. 228 It has been found that SKOV3 cells cultured in an ultra‐low apposition system exhibit anoikis resistance. The key factor may be the lncRNA HOX transcript antisense RNA (HOTAIR), which may contribute to anoikis resistance by recruiting EZH2 and affecting H3K27 methylation to enhance sphere formation in ovarian cancer cells. This may be one of the mechanisms of ovarian cancer metastasis and chemoresistance, so the anoikis regulatory pathway mechanism based on HOTAIR provides a possible pathway to target tumor metastasis and chemoresistance. 226 Some studies have investigated the mechanisms underlying anoikis resistance in the suspension culture of ovarian cancer spheroids and demonstrated that modifications in the mitochondrial activity was induced by visfatin, suggesting that visfatin is a potential new therapeutic target for the treatment of peritoneal disseminated ovarian cancer. 102 Wang et al. developed an ECM deprivation system (EDS) to regulate anoikis. Based on previous studies, fibronectin was found to have a direct regulatory effect on ECM‐mediated anoikis resistance and cell adhesion‐mediated drug resistance. 238 Therefore, the EDS constructed based on FN‐targeted self‐assembling peptides could reverse anoikis resistance by blocking FN signaling, while improving chemotherapeutic drug sensitivity, which is an innovative way of anoikis regulation and provides new ideas for anoikis‐based drug sensitivity regulation. 228 In vivo studies also have similar findings. For example, during the process of tumor peritoneal metastasis, individual cancer cell suspended in peritoneal fluid can aggregate to form multicellular spheroids. This cellular arrangement confers resistance to anoikis, apoptosis, and chemotherapeutic agents. 239

Therefore, based on the clear link between anoikis and tumor metastasis as well as drug resistance, the molecular pathways of anoikis are considered to be highly promising therapeutic and intervention targets. For instance, HMGA1 was found to promote anoikis resistance in pancreatic cancer cells through PI3‐K/Akt‐dependent mechanism, whereas inhibition of PI3‐K/Akt by the small molecule inhibitor LY294002 or dominant‐negative Akt could reverse this cell fate. Given the association between anoikis resistance and the PI3‐K/Akt pathway, HMGA1 was regarded as a potential therapeutic target for pancreatic cancer. 240 Claudin‐1 has been shown to play a role in promoting metastasis and anoikis resistance in colorectal cancer. 241 , 242 , 243 In addition, Claudin‐1 has also been implicated in tumor stemness and chemoresistance‐related signaling pathways and promotes stemness and chemoresistance by increasing EPHA2 expression, downstream AKT signal transduction, and CD44 expression. Therefore, Claudin‐1 is considered as a highly promising target for drug intervention. 244 For chemoresistance in prostate cancer treatment, the epithelial‐mesenchymal transition process mediated by TGF‐β confers stemness, which in turn promotes tumor migration and chemoresistance through anoikis resistance. 245 DZ‐50 was found to induce anoikis and show certain therapeutic effects. 246 Moreover, tumor‐infiltrating adipose stem cells promoted glycolysis and anoikis resistance in colorectal cancer cells, and ultimately resulted in peritoneal metastasis through the TGF‐β1/SMAD3/ANGPTL4 axis. Dual targeting of TGF‐β signaling and ANGPTL4 may be a viable therapeutic strategy for peritoneal metastasis of colorectal cancer. 247 These suggest that more mechanisms about anoikis regulatory have yet to be explored for application in drug therapy.

5.3 Anoikis and cell‐based therapies

Anoikis has demonstrated significant potential in the field emerging cell‐based therapies. Its influence on maintaining cell stemness for oncology research and its impact on the viability of engineered stem cells in therapeutic applications are particularly.

For tumor stem cells, anoikis resistance of tumor cells is an important part of their increased stemness. 46 Fibrinolytic factor can promote the survival and growth of tumor cells by interfering with cell anoikis resistance to provide more survival opportunities for the cells. 248 TrkB has also been reported to enhance cell metastasis by increasing anoikis resistance, 249 and interestingly, it also promotes stemness in hepatocellular carcinoma cells by increasing the stability of DJ‐1, aiding in tumor progression. 250 Liu et al. 251 established a therapeutic strategy in triple‐negative breast cancer by targeting the tumor stemness. They found Tetrandrine, a natural plant alkaloid, can effectively inhibit breast cancer stem cell characteristics by promoting anoikis, and is therefore considered a potential antitumor drug. 251 RhoC has also been proved to regulate a variety of cellular phenotypes including metastasis and anoikis resistance, and thereby conferring plasticity to help the cells gain more viability. Thus, RhoC is considered as a cancer stem cell therapeutic target. 252

In addition, for engineered stem cells such as ESCs and iPSC, they have many problems such as difficulties in in vitro culture, expansion and preservation, 253 , 254 and the maintenance of their activity for therapeutic use remains an insurmountable problem, 255 which severely limits their use in many cell‐based therapies. Considering the adhesion‐dependent properties required for most stem cells, overcoming anoikis to help cells gain more survival activity becomes a promising direction. 256 One of the important problems in cell transplantation is the degrafting‐induced anoikis. Frisco‐Cabanos et al. 140 have found that water‐soluble molecules can protect suspension cells from anoikis by integrin‐mediated and thus increase cell survival. For some neurodegenerative diseases, the therapeutic strategy of cell transplantation has been fraught with difficulties centered on improving cell survival after transplantation, and anoikis is likely to be an important cause of cell death after neuronal transplantation to the brain. 257 Of course, some gel systems or adhesion matrices can help to improve cell survival. 258 Schaschkow et al. 167 reported that a hydroxypropyl methylcellulose hydrogel can help to reduce anoikis and promote blood vessel formation in islet transplantation, which is extremely valuable for glycemic control in diabetes. hESC‐CMs transplantation in cardiac research showed that cotransplantation of biocompatible materials or hydrogels with hESC‐CMs could promote cellular anoikis resistance, which in turn increased hESC‐CMs’ survival after transplantation and promote the recovery of cardiac function. 144 All these are as Michel 170 emphasized that anoikis is extremely helpful in cardiovascular system diseases for the pathological remission. Similarly, hESC‐RPE has been verified to undergo anoikis during therapy due to factors like ECM segregation and serum deprivation. Therefore, hESC‐RPE cells that overcome anoikis hold promise as an in vitro model for stem cell therapy. 132

In summary, the application potential of anoikis in cell‐based therapies is still far from being explored. For solving the problem of tumor cell stemness, anoikis‐related signaling remains to be studied as an important therapeutic target. On the other hand, in the engineering application of stem cells, it is reasonable to solve the pre‐ and post‐treatment survival of cells based on anoikis regulation. Therefore, anoikis has great potential for research in stem cell differentiation, cell transplantation and other cell‐based therapies.

6 CONCLUSION AND PROSPECTS

Since the establishment of the concept of apoptosis in 1972, 259 research on cell death has never ceased, making it a crucial area of study in understanding cell fate. 260 , 261 The discovery and research of emerging death modes, including anoikis, 7 disulfidptosis, 262 cuproptosis, 263 and paraptosis, 264 are advancing human understanding and application of cell biology. The primary tool for these investigations has been the in vitro cell model. As a fundamental model in biomedical research, cell models have been extensively utilized to simulate the physiological and pathological environments in the body. 265 However, the significant differences between these traditional research models and the in vivo microenvironment have raised concerns among researchers in the fields of developmental biology, pathology, and pharmacology. 266 In particular, with the emergence of genetically engineered animal models 267 and organoids, 268 , 269 conventional 2D cell culture in vitro can no longer meet the demands of rapidly advancing research. 270 Consequently, cell coculture systems, 271 3D culture systems, 272 and cell culture protocols based on biomaterials 273 have been developed to address a crucial issue—creating an environment that closely resembles the in vivo growth conditions. This includes the construction of ECM suitable for cell survival, which undoubtedly contributes to recapitulating the programmed cell death states. 274

Traditional cell models include primary cell models, which are derived from their original tissue but no longer retain the growth state of the primary cells. These models undergo significant genomics 275 , 276 and epigenomics, 277 regulations, and the impact of the ECM on cell adhesion, migration, and cell fate (including cell death), are more immediate and direct. 93 , 278 Anoikis, as an important programmed cell death mode regulated by the ECM, determines the fate of cells from the moment they detach from their original environment and undergo in vitro screening and culture. It is for this reason that only cells capable of adapting to the new environment have the potential to survive. This implies that the initial round of anoikis phenotype regulation occurs at the onset of cell detachment and continues until the cells establish a new adhesive growth system. 118 , 279 Therefore, we currently cannot fully address whether the research based on these newly established cell models with adaptive changes reflects the true in vivo behavioral and genomic states. However, when focusing on the study of the cell death fate process, it is essential to maintain as much consistency as possible with the in vivo environment in the anoikis process regulated by the ECM. This may have unexpected value in recapitulating cell behavioral states and micro‐scale genetic information.

For engineered cells such as ESCs, iPSCs, and so on, their research direction is relatively pure. Researchers often focus more on their functional extensions rather than their original survival states. 280 Due to their high pluripotency and strong differentiation potential, 85 these cells exhibit significant adaptability and changes. Therefore, researchers are more concerned with finding the most suitable growth environment for these cells rather than the original one. Similarly, this applies to the transformation research of functional derivative cell lines. 281 Currently, there are significant limitations in the culture, differentiation, and storage of stem cells, 282 including challenges in proliferation, 283 efficiency of differentiation, 284 and interference in cryopreservation. 285 A core issue being addressed is the reduction of cell death, especially ECM‐mediated anoikis. The strategies employed are imaginative and include genomic regulation, 286 upgrading of culture media, 287 and changes in matrix conditions. 288 Researchers have also developed various biomaterials to assist in the growth and proliferation of stem cells, including specialized material surfaces, 289 hydrogel systems, 290 and nanotopography, 291 all of which have been reported to varying degrees to resist anoikis. Although some studies suggest that pathways such as ferroptosis also participate in the process of stem cell detachment‐induced death, 292 the inhibition of anoikis‐mediated stem cell growth and differentiation remains a major potential direction.

Of course, anoikis also participates in a wide range of physiological and pathological processes. Since the development of the fertilized egg, the fate of death has been engraved in the genetic code of every cell. 293 In the early stages of embryonic development, organ formation begins, accompanied by the initiation of distal migration. And the exact cell fate during this period remains unclear, which could involve survival through resistance to anoikis or adaptive survival of anoikis‐resistant cells. In the process of cellular aging, cell death often accompanies cell detachment and clearance from the body. 294 Anoikis is an important component of cellular senescence and involved in various pathological processes, including diabetes, cardiovascular diseases, tumor metastasis and more. 79 Whether targeting anoikis is a potential therapeutic target is still unclear. 295 However, this does not mean that anoikis cannot be involved in disease treatment interventions.

Studies of anoikis‐based therapeutic interventions in tumor metastasis, drug resistance have been reported, 184 , 296 and more anoikis agents are under intense experimental investigation. 206 Some drugs that have been in clinical use for a long time have shown to regulate anoikis and thus affect cell fate. 237 Natural products, polysaccharide, 297 small molecules such as A‐1210477, 298 and nanomedicines such as human serum albumin combined with doxorubicin 299 have also shown inhibitory effects on anoikis resistance. The agents targeted in integrin have also been explored in numerous clinical trials, and they are all highly promising agents for anoikis intervention. Thus anoikis‐based regulation is certainly helpful in drug therapy. On the other hand, cell therapies based on stem cells are currently considered to have significant development potential in various fields such as tissue repair, Alzheimer's disease, and cancer. 300 , 301 , 302 Preliminary results have been achieved with stem cell and cell transplantation therapies that assist in resisting anoikis. 140 In oncology research, chimeric antigen receptor‐T cell therapies, 303 T cell receptor‐T cell therapies, 304 and tumor‐infiltrating lymphocyte therapies, 305 which are currently receiving considerable attention, may also need to consider the interfering factors of anoikis in cellular fate. Finally, cell–cell interactions 118 , 306 and microbial signaling, 307 which are also part of extracellular signals, may regulate the process of anoikis. Indeed, the ultimate goal is to improve the patient benefit of cell‐based therapy by increasing the activity of various types of engineered stem cells through various physicochemical means. All of these indicate that anoikis acts as a hidden player in the regulation of cell fate and physiopathology process. Exploring the interplay between external signals and micro‐mechanisms could suggest valuable research directions for therapeutic interventions.

In summary, anoikis is a distinct form of apoptosis that cannot be simply categorized as traditional apoptosis due to its unique initiation process, which including extracellular physical and chemical stimuli triggering changes in the ECM. Anoikis plays a broader role in cell fate, as well as physiological and pathological regulatory processes, and presents new challenges and opportunities for the self‐detection of engineered cell states and cutting‐edge applications. Therefore, the therapeutic potential of targeting anoikis in drug therapies and cell‐based treatments attracts focused attention. Further studies are required to identify the genetic regulators, chemicals, and novel culture materials that can specifically target the anoikis. Such advancements could address the challenges proposed in this review, enhance the establishment of in vitro cell models and stem cells induction, and ultimately facilitate the application of anoikis‐based interventional therapies in the clinic for the benefit of patients.

AUTHOR CONTRIBUTIONS

Jie Mei, Lei‐Yun Wang, Ji‐Ye Yin and Peng‐Yuan Wang conceived the manuscript. Jie Mei, Xue‐Yao Jiang, Hui‐Xiang Tian, and Jia‐Nan Song primarily searched for the papers and made the outline. Jie Mei, Hui‐Xiang Tian, and Jia‐Nan Song wrote the initial draft; Jie Mei, Ding‐Chao Rong, LuozixianWang, Jia‐Nan Song, and Lei‐Yun Wang polished the manuscript. Jie Mei, Hui‐Xiang Tian, Ding‐Chao Rong, Xue‐Yao Jiang, and Yuan‐Shen Chen designed and drew the figures. Xue‐Yao Jiang and Hui‐Xiang Tian checked all references and formatting. Ji‐Ye Yin, Peng‐Yuan Wang, Raymond C. B.Wong, Cheng‐Xian Guo, and Lian‐Sheng Wang reviewed the manuscript and provided suggestions for revision. All authors revised and contributed to the final version of the manuscript.

CONFLICT OF INTEREST STATEMENT

The authors declare no conflict of interest.

ETHICS STATEMENT

Not applicable.

ACKNOWLEDGMENTS

J. Y. Y. thanks the support from the National Natural Science Foundation of China (82373962, 82073943); and Scientific research project of Furong laboratory of Central South University (2023SK2083). P. Y. W. thanks the support from the Ministry of Science and Technology of China (2022YFA1105101); the Zhejiang Provincial Natural Science Foundation of China (LZ23C070004). R. C. B. W. is supported by National Health and Medical Research Council (GNT1184076). L. S. W. thanks the support from the Natural Science Foundation of Hunan Province (2021JJ80087). C. X. G. thanks the Major Research Project for High‐Level Health and Wellness Talents of Hunan Province (R2023042), the Natural Science Foundation of Hunan Province (2023JJ30822), and the Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South University (YX202110). The Center for Eye Research Australia receive Operational Infrastructure Support from the Victorian State Government. Figures were created with biorender.com.

DATA AVAILABILITY STATEMENT

Not applicable.
==== Refs
REFERENCES

1 Park D , Wershof E , Boeing S , et al. Extracellular matrix anisotropy is determined by tfap2c‐dependent regulation of cell collisions. Nat Mater. 2020;19 (2 ):227‐238.31659294
2 Long KR , Newland B , Florio M , et al. Extracellular matrix components hapln1, lumican, and collagen i cause hyaluronic acid‐dependent folding of the developing human neocortex. Neuron. 2018;99 (4 ):702‐719.30078576
3 Song J , Lokmic Z , Lämmermann T , et al. Extracellular matrix of secondary lymphoid organs impacts on b‐cell fate and survival. Proc Natl Acad Sci USA. 2013;110 (31 ):E2915‐E2924.23847204
4 Bateman JF , Boot‐Handford RP , Lamandé SR . Genetic diseases of connective tissues: cellular and extracellular effects of ecm mutations. Nat Rev Genet. 2009;10 (3 ):173‐183.19204719
5 Naba A , Clauser KR , Hoersch S , Liu H , Carr SA , Hynes RO . The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteomics. 2012;11 (4 ):M111‐M14647.
6 Zhang D , Feng F , Li Q , Wang X , Yao L . Nanopurpurin‐based photodynamic therapy destructs extracellular matrix against intractable tumor metastasis. Biomaterials. 2018;173 :22‐33.29734018
7 Frisch SM , Francis H . Disruption of epithelial cell‐matrix interactions induces apoptosis. J Cell Biol. 1994;124 (4 ):619‐626.8106557
8 Macabenta F , Sun H , Stathopoulos A . Bmp‐gated cell‐cycle progression drives anoikis during mesenchymal collective migration. Dev Cell. 2022;57 (14 ):1683‐1693.35709766
9 Fanfone D , Wu Z , Mammi J , et al. Confined migration promotes cancer metastasis through resistance to anoikis and increased invasiveness. eLife. 2022;11 :e73150.35256052
10 Alanko J , Mai A , Jacquemet G , et al. Integrin endosomal signalling suppresses anoikis. Nat Cell Biol. 2015;17 (11 ):1412‐1421.26436690
11 Galluzzi L , Vitale I , Aaronson SA , et al. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell Death Differ. 2018;25 (3 ):486‐541.29362479
12 Adair BD , Xiong J , Yeager M , Arnaout MA . Cryo‐em structures of full‐length integrin αiibβ3 in native lipids. Nat Commun. 2023;14 (1 ):4168.37443315
13 Jo MH , Li J , Jaumouillé V , et al. Single‐molecule characterization of subtype‐specific β1 integrin mechanics. Nat Commun. 2022;13 (1 ):7471.36463259
14 Hu Q , Bian Q , Rong D , et al. Jak/stat pathway: extracellular signals, diseases, immunity, and therapeutic regimens. Front Bioeng Biotechnol. 2023;11 :1110765.36911202
15 Giancotti FG , Ruoslahti E . Integrin signaling. Science. 1999;285 (5430 ):1028‐1032.10446041
16 Okayama H . Cell cycle control by anchorage signaling. Cell Signal. 2012;24 (8 ):1599‐1609.22522183
17 Dai Y , Zhang X , Ou Y , et al. Anoikis resistance–protagonists of breast cancer cells survive and metastasize after ecm detachment. Cell Commun Signal. 2023;21 (1 ):190.37537585
18 Chen H , Ma J , Liu J , et al. Lysophosphatidylcholine disrupts cell adhesion and induces anoikis in hepatocytes. Febs Lett. 2022;596 (4 ):510‐525.35043979
19 Jülich D , Cobb G , Melo AM , et al. Cross‐scale integrin regulation organizes ecm and tissue topology. Dev Cell. 2015;34 (1 ):33‐44.26096733
20 Mukherjee A , Melamed S , Damouny‐Khoury H , et al. Α‐catenin links integrin adhesions to f‐actin to regulate ecm mechanosensing and rigidity dependence. J Cell Biol. 2022;221 (8 ):e202102121.35652786
21 Antalíková J , Sečová P , Michalková K , Horovská Ľ , Páleníková V , Jankovičová J . Expression of αv integrin and its potential partners in bull reproductive tissues, germ cells and spermatozoa. Int J Biol Macromol. 2022;209 (A ):542‐551. Pt.35413326
22 Sebé‐Pedrós A , Roger AJ , Lang FB , King N , Ruiz‐Trillo I . Ancient origin of the integrin‐mediated adhesion and signaling machinery. Proc Natl Acad Sci USA. 2010;107 (22 ):10142‐10147.20479219
23 Dessapt C , Baradez MO , Hayward A , et al. Mechanical forces and tgfbeta1 reduce podocyte adhesion through alpha3beta1 integrin downregulation. Nephrol Dial Transplant. 2009;24 (9 ):2645‐2655.19420102
24 Chen S , Zheng Y , Ran X , et al. Integrin αeβ7(+) t cells direct intestinal stem cell fate decisions via adhesion signaling. Cell Res. 2021;31 (12 ):1291‐1307.34518654
25 Slack RJ , Macdonald SJF , Roper JA , Jenkins RG , Hatley RJD . Emerging therapeutic opportunities for integrin inhibitors. Nat Rev Drug Discov. 2022;21 (1 ):60‐78.34535788
26 Kamarajan P , Kapila YL . An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of fak and erk. Apoptosis. 2007;12 (12 ):2221‐2231.17879163
27 Hsieh Y , van der Heyde H , Oh E , Guan J , Chang P . Osteopontin mediates tumorigenic transformation of a preneoplastic murine cell line by suppressing anoikis: an arg‐gly‐asp‐dependent‐focal adhesion kinase‐caspase‐8 axis. Mol Carcinog. 2015;54 (5 ):379‐392.24249517
28 Hall ER , Slack RJ . The effect of divalent metal cations on the αv integrin binding site is ligand and integrin specific. Biomed Pharmacother. 2019;110 :362‐370.30529769
29 Halim H , Chanvorachote P . Long‐term hydrogen peroxide exposure potentiates anoikis resistance and anchorage‐independent growth in lung carcinoma cells. Cell Biol Int. 2012;36 (11 ):1055‐1066.22931092
30 Wang X , Ji L , Wang J , Liu C . Matrix stiffness regulates osteoclast fate through integrin‐dependent mechanotransduction. Bioact Mater. 2023;27 :138‐153.37064801
31 Li S , Chen Y , Zhang Y , et al. Shear stress promotes anoikis resistance of cancer cells via caveolin‐1‐dependent extrinsic and intrinsic apoptotic pathways. J Cell Physiol. 2019;234 (4 ):3730‐3743.30171601
32 Kyjacova L , Hubackova S , Krejcikova K , et al. Radiotherapy‐induced plasticity of prostate cancer mobilizes stem‐like non‐adherent, erk signaling‐dependent cells. Cell Death Differ. 2015;22 (6 ):898‐911.25012501
33 Supino R , Scovassi AI , Croce AC , et al. Biological effects of a new vacuolar‐h,‐atpase inhibitor in colon carcinoma cell lines. Ann N Y Acad Sci. 2009;1171 :606‐616.19723111
34 Hsu L , Ho Y , Chuang E , et al. Effects of ph on molecular mechanisms of chitosan‐integrin interactions and resulting tight‐junction disruptions. Biomaterials. 2013;34 (3 ):784‐793.23103155
35 Lee H , Yang W , Hour M , et al. Photodynamic activity of aloe‐emodin induces resensitization of lung cancer cells to anoikis. Eur J Pharmacol. 2010;648 (1‐3 ):50‐58.20840846
36 Arzani H , Rafii‐Tabar H , Ramezani F . The investigation into the effect of the length of rgd peptides and temperature on the interaction with the αiibβ3 integrin: a molecular dynamic study. J Biomol Struct Dyn. 2022;40 (20 ):9701‐9712.34060983
37 Ishikawa F , Ushida K , Mori K , Shibanuma M . Loss of anchorage primarily induces non‐apoptotic cell death in a human mammary epithelial cell line under atypical focal adhesion kinase signaling. Cell Death Dis. 2015;6 (1 ):e1619.25611393
38 Sun H , Lagarrigue F , Gingras AR , Fan Z , Ley K , Ginsberg MH . Transmission of integrin β7 transmembrane domain topology enables gut lymphoid tissue development. J Cell Biol. 2018;217 (4 ):1453‐1465.29535192
39 Derouet M , Wu X , May L , et al. Acquisition of anoikis resistance promotes the emergence of oncogenic k‐ras mutations in colorectal cancer cells and stimulates their tumorigenicity in vivo. Neoplasia. 2007;9 (7 ):536‐545.17710156
40 Que Z , Yang Y , Liu H , et al. Jinfukang regulates integrin/src pathway and anoikis mediating circulating lung cancer cells migration. J Ethnopharmacol. 2021;267 :113473.33068649
41 Jiang G , Song C , Wang X , et al. The multi‐omics analysis identifies a novel cuproptosis‐anoikis‐related gene signature in prognosis and immune infiltration characterization of lung adenocarcinoma. Heliyon. 2023;9 (3 ):e14091.36967927
42 Liang H , Xiang L , Wu H , Liu Y , Tian W , Zeng J . Anoikis‐related long non‐coding rna signatures to predict prognosis and small molecular drug response in cervical cancer. Front Pharmacol. 2023;14 :1135626.37021052
43 Guizhen Z , Weiwei Z , Yun W , Guangying C , Yize Z , Zujiang Y . An anoikis‐based signature for predicting prognosis in hepatocellular carcinoma with machine learning. Front Pharmacol. 2022;13 :1096472.36686684
44 Xie T , Peng S , Liu S , et al. Multi‐cohort validation of ascore: an anoikis‐based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer. Mol Cancer. 2024;23 (1 ):30.38341586
45 Jin L , Chun J , Pan C , et al. The plag1‐gdh1 axis promotes anoikis resistance and tumor metastasis through camkk2‐ampk signaling in lkb1‐deficient lung cancer. Mol Cell. 2018;69 (1 ):87‐99.29249655
46 Sun Z , Zhao Y , Wei Y , Ding X , Tan C , Wang C . Identification and validation of an anoikis‐associated gene signature to predict clinical character, stemness, idh mutation, and immune filtration in glioblastoma. Front Immunol. 2022;13 :939523.36091049
47 Yu X , Cohen DM , Chen CS . Mir‐125b is an adhesion‐regulated microrna that protects mesenchymal stem cells from anoikis. Stem Cells. 2012;30 (5 ):956‐964.22331826
48 Luchetti F , Mannello F , Canonico B , et al. Integrin and cytoskeleton behaviour in human neuroblastoma cells during hyperthermia‐related apoptosis. Apoptosis. 2004;9 (5 ):635‐648.15314292
49 Takada Y , Ye X , Simon S . The integrins. Genome Biol. 2007;8 (5 ):215.17543136
50 Huang W , Yu D , Wang M , et al. Itgbl1 promotes cell migration and invasion through stimulating the tgf‐β signalling pathway in hepatocellular carcinoma. Cell Prolif. 2020;53 (7 ):e12836.32537856
51 Jumper J , Evans R , Pritzel A , et al. Highly accurate protein structure prediction with alphafold. Nature. 2021;596 (7873 ):583‐589.34265844
52 Varadi M , Bertoni D , Magana P , et al. Alphafold protein structure database in 2024: providing structure coverage for over 214 million protein sequences. Nucleic Acids Res. 2024;52 (D1 ):D368‐D375.37933859
53 Pang X , He X , Qiu Z , et al. Targeting integrin pathways: mechanisms and advances in therapy. Signal Transduct Target Ther. 2023;8 (1 ):1.36588107
54 Tomasello B , Di Mauro MD , Malfa GA , et al. Rapha myr(®), a blend of sulforaphane and myrosinase, exerts antitumor and anoikis‐sensitizing effects on human astrocytoma cells modulating sirtuins and dna methylation. Int J Mol Sci. 2020;21 (15 ):5328.32727075
55 Walsh N , Clynes M , Crown J , O'Donovan N . Alterations in integrin expression modulates invasion of pancreatic cancer cells. J Exp Clin Cancer Res. 2009;28 (1 ):140.19825166
56 de Sousa Mesquita AP , de Araújo Lopes S , Pernambuco Filho PCA , Nader HB , Lopes CC . Acquisition of anoikis resistance promotes alterations in the ras/erk and pi3k/akt signaling pathways and matrix remodeling in endothelial cells. Apoptosis. 2017;22 (9 ):1116‐1137.28653224
57 Rohwer N , Welzel M , Daskalow K , et al. Hypoxia‐inducible factor 1alpha mediates anoikis resistance via suppression of alpha5 integrin. Cancer Res. 2008;68 (24 ):10113‐10120.19074877
58 Genduso S , Freytag V , Schetler D , et al. Tumor cell integrin β4 and tumor stroma e‐/p‐selectin cooperatively regulate tumor growth in vivo. J Hematol Oncol. 2023;16 (1 ):23.36932441
59 Ray U , Jung D , Jin L , et al. Targeting lrrc15 inhibits metastatic dissemination of ovarian cancer. Cancer Res. 2022;82 (6 ):1038‐1054.34654724
60 Aslan B , Monroig P , Hsu M , et al. The znf304‐integrin axis protects against anoikis in cancer. Nat Commun. 2015;6 :7351.26081979
61 Wu Y , Zuo J , Ji G , et al. Proapoptotic function of integrin beta(3) in human hepatocellular carcinoma cells. Clin Cancer Res. 2009;15 (1 ):60‐69.19118033
62 Satyavarapu EM , Das R , Mandal C , Mukhopadhyay A , Mandal C . Autophagy‐independent induction of lc3b through oxidative stress reveals its non‐canonical role in anoikis of ovarian cancer cells. Cell Death Dis. 2018;9 (10 ):934.30224639
63 Guha D , Saha T , Bose S , et al. Integrin‐egfr interaction regulates anoikis resistance in colon cancer cells. Apoptosis. 2019;24 (11‐12 ):958‐971.31641961
64 Konttinen YT , Fuellen G , Bing Y , et al. Sex steroids in sjögren's syndrome. J Autoimmun. 2012;39 (1‐2 ):49‐56.22300712
65 Kozlova NI , Morozevich GE , Gevorkian NM , Berman AE . Implication of integrins α3β1 and α5β1 in invasion and anoikis of sk‐mel‐147 human melanoma cells: non‐canonical functions of protein kinase akt. Aging. 2020;12 (23 ):24345‐24356.33260159
66 Song J , Shen Y , Mou H , et al. Living‐dna nanogel appendant enables in situ modulation and quantification of regulation effects on membrane proteins. Acs Appl Bio Mater. 2021;4 (5 ):4565‐4574.
67 Erdreich‐Epstein A , Tran LB , Cox OT , et al. Endothelial apoptosis induced by inhibition of integrins alphavbeta3 and alphavbeta5 involves ceramide metabolic pathways. Blood. 2005;105 (11 ):4353‐4361.15705795
68 Janes SM , Watt FM . Switch from alphavbeta5 to alphavbeta6 integrin expression protects squamous cell carcinomas from anoikis. J Cell Biol. 2004;166 (3 ):419‐431.15289499
69 Lino RLB , Dos Santos PK , Pisani GFD , Altei WF , Cominetti MR , Selistre‐De‐Araújo HS . Alphavbeta3 integrin blocking inhibits apoptosis and induces autophagy in murine breast tumor cells. Biochim Biophy Acta Mol Cell Res. 2019;1866 (12 ):118536.
70 Benoit YD , Larrivée J , Groulx J , Stankova J , Vachon PH , Beaulieu J . Integrin alpha8beta1 confers anoikis susceptibility to human intestinal epithelial crypt cells. Biochem Biophys Res Commun. 2010;399 (3 ):434‐439.20678483
71 Maubant S , Saint‐Dizier D , Boutillon M , et al. Blockade of alpha v beta3 and alpha v beta5 integrins by rgd mimetics induces anoikis and not integrin‐mediated death in human endothelial cells. Blood. 2006;108 (9 ):3035‐3044.16835373
72 Haun F , Neumann S , Peintner L , et al. Identification of a novel anoikis signalling pathway using the fungal virulence factor gliotoxin. Nat Commun. 2018;9 (1 ):3524.30166526
73 Beaulieu J . Integrin α6β4 in colorectal cancer: expression, regulation, functional alterations and use as a biomarker. Cancers (Basel). 2019;12 (1 ):41.31877793
74 Seifert A , Posern G . Tightly controlled mrtf‐a activity regulates epithelial differentiation during formation of mammary acini. Breast Cancer Res. 2017;19 (1 ):68.28592291
75 Gilmore AP . Anoikis. Cell Death Differ. 2005;12 :1473‐1477. Suppl 2.16247493
76 Jenning S , Pham T , Ireland SK , Ruoslahti E , Biliran H . Bit1 in anoikis resistance and tumor metastasis. Cancer Lett. 2013;333 (2 ):147‐151.23376255
77 Brentnall M , Weir DB , Rongvaux A , Marcus AI , Boise LH . Procaspase‐3 regulates fibronectin secretion and influences adhesion, migration and survival independently of catalytic function. J Cell Sci. 2014;127 (10 ):2217‐2226. Pt.24610949
78 Nano M , Mondo JA , Harwood J , Balasanyan V , Montell DJ . Cell survival following direct executioner‐caspase activation. Proc Natl Acad Sci USA. 2023;120 (4 ):e2078436176.
79 Taddei ML , Giannoni E , Fiaschi T , Chiarugi P . Anoikis: an emerging hallmark in health and diseases. J Pathol. 2012;226 (2 ):380‐393.21953325
80 Yu S , Ji H , Dong X , Liu A , Yu J . Fas/fas‐l‐mediated apoptosis and autophagy of spc‐a‐1 cells induced by water‐soluble polysaccharide from polygala tenuifolia. Int J Biol Macromol. 2020;150 :449‐458.32027895
81 Scaffidi C , Fulda S , Srinivasan A , et al. Two cd95 (apo‐1/fas) signaling pathways. EMBO J. 1998;17 (6 ):1675‐1687.9501089
82 Mei J , Tian H , Huang H , et al. Ccne1 is a potential target of metformin for tumor suppression of ovarian high‐grade serous carcinoma. Cell Cycle. 2023;22 (1 ):85‐99.36004387
83 Scherer WF , Syverton JT , Gey GO . Studies on the propagation in vitro of poliomyelitis viruses. Iv. Viral multiplication in a stable strain of human malignant epithelial cells (strain hela) derived from an epidermoid carcinoma of the cervix. J Exp Med. 1953;97 (5 ):695‐710.13052828
84 Ma H , Jiang S , Du L , et al. Conditioned medium from primary cytotrophoblasts, primary placenta‐derived mesenchymal stem cells, or sub‐cultured placental tissue promoted huvec angiogenesis in vitro. Stem Cell Res Ther. 2021;12 (1 ):141.33596987
85 Takahashi K , Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126 (4 ):663‐676.16904174
86 Rossi G , Manfrin A , Lutolf MP . Progress and potential in organoid research. Nat Rev Genet. 2018;19 (11 ):671‐687.30228295
87 Budhwani KI , Patel ZH , Guenter RE , Charania AA . A hitchhiker's guide to cancer models. Trends Biotechnol. 2022;40 (11 ):1361‐1373.35534320
88 Song J , Liu K , Mei J , et al. Defined surface physicochemical cues inhibit m1 polarization of human macrophages using colloidal self‐assembled patterns. ACS Appl Mater Interfaces. 2023;15 (30 ):35832‐35846.37489656
89 Wang MT , Pang SW . Enhancing nasopharyngeal carcinoma cell separation with selective fibronectin coating and topographical modification on polydimethylsiloxane scaffold platforms. Int J Mol Sci. 2023;24 (15 ):12409.37569784
90 Pang Z , Pan Z , Ma M , et al. Nanostructured coating of non‐crystalline tantalum pentoxide on polyetheretherketone enhances rbms cells/hge cells adhesion. Int J Nanomed. 2021;16 :725‐740.
91 Di Claudio F , Muglia CI , Smaldini PL , et al. Use of a collagen membrane to enhance the survival of primary intestinal epithelial cells. J Cell Physiol. 2017;232 (9 ):2489‐2496.27626762
92 Chiarugi P , Giannoni E . Anoikis: a necessary death program for anchorage‐dependent cells. Biochem Pharmacol. 2008;76 (11 ):1352‐1364.18708031
93 Hoshiba T , Nagahara H , Cho C , Tagawa Y , Akaike T . Primary hepatocyte survival on non‐integrin‐recognizable matrices without the activation of akt signaling. Biomaterials. 2007;28 (6 ):1093‐1104.17081603
94 Casarrubios L , Matesanz MC , Sánchez‐Salcedo S , Arcos D , Vallet‐Regí M , Portolés MT . Nanocrystallinity effects on osteoblast and osteoclast response to silicon substituted hydroxyapatite. J Colloid Interface Sci. 2016;482 :112‐120.27497232
95 Alcaide M , Serrano M , Roman J , et al. Suppression of anoikis by collagen coating of interconnected macroporous nanometric carbonated hydroxyapatite/agarose scaffolds. J Biomed Mater Res A. 2010;95 (3 ):793‐800.20725989
96 Koroknai V , Patel V , Szász I , Ádány R , Balazs M . Gene expression signature of braf inhibitor resistant melanoma spheroids. Pathol Oncol Res. 2020;26 (4 ):2557‐2566.32613561
97 Ko E , Poon MLS , Park E , Cho Y , Shin JH . Engineering 3d cortical spheroids for an in vitro ischemic stroke model. Acs Biomater Sci Eng. 2021;7 (8 ):3845‐3860.34275269
98 Deng S , Zhu Y , Zhao X , Chen J , Tuan RS , Chan HF . Efficient fabrication of monodisperse hepatocyte spheroids and encapsulation in hybrid hydrogel with controllable extracellular matrix effect. Biofabrication. 2021;14 (1 ). doi:10.1088/1758-5090/ac2b89
99 Fiorotto R , Mariotti V , Taleb SA , et al. Cell‐matrix interactions control biliary organoid polarity, architecture, and differentiation. Hepatol Commun. 2023;7 (4 ):e94.
100 Krutty JD , Dias AD , Yun J , Murphy WL , Gopalan P . Synthetic, chemically defined polymer‐coated microcarriers for the expansion of human mesenchymal stem cells. Macromol Biosci. 2019;19 (2 ):e1800299.30565870
101 Lin X , Zhang K , Wei D , et al. The impact of spaceflight and simulated microgravity on cell adhesion. Int J Mol Sci. 2020;21 (9 ):3031.32344794
102 Gogola‐Mruk J , Tworzydło W , Krawczyk K , Marynowicz W , Ptak A . Visfatin induces ovarian cancer resistance to anoikis by regulating mitochondrial activity. Endocrine. 2023;80 (2 ):448‐458.36658296
103 Kleinschmidt EG , Miller NLG , Ozmadenci D , et al. Rgnef promotes ovarian tumor progression and confers protection from oxidative stress. Oncogene. 2019;38 (36 ):6323‐6337.31308489
104 Dolinschek R , Hingerl J , Benge A , et al. Constitutive activation of integrin αvβ3 contributes to anoikis resistance of ovarian cancer cells. Mol Oncol. 2021;15 (2 ):503‐522.33155399
105 Gao W , Wu D , Wang Y , et al. Development of a novel and economical agar‐based non‐adherent three‐dimensional culture method for enrichment of cancer stem‐like cells. Stem Cell Res Ther. 2018;9 (1 ):243.30257704
106 Smith KA , Dang M , Baker AEG , Fuehrmann T , Fokina A , Shoichet MS . Synthesis of an enzyme‐mediated reversible cross‐linked hydrogel for cell culture. Biomacromolecules. 2021;22 (12 ):5118‐5127.34752066
107 Wang C , Gong Y , Zhong Y , Yao Y , Su K , Wang D . The control of anchorage‐dependent cell behavior within a hydrogel/microcarrier system in an osteogenic model. Biomaterials. 2009;30 (12 ):2259‐2269.19152973
108 Sun Y , Chi X , Meng H , et al. Polylysine‐decorated macroporous microcarriers laden with adipose‐derived stem cells promote nerve regeneration in vivo. Bioact Mater. 2021;6 (11 ):3987‐3998.33997488
109 Li X , Li X , Yang J , et al. Living and injectable porous hydrogel microsphere with paracrine activity for cartilage regeneration. Small (Weinheim an Der Bergstrasse, Germany). 2023;19 (17 ):e2207211.36651038
110 Capeling MM , Huang S , Childs CJ , et al. Suspension culture promotes serosal mesothelial development in human intestinal organoids. Cell Rep. 2022;38 (7 ):110379.35172130
111 Ogawa I , Onozato D , Anno S , et al. Suspension culture of human induced pluripotent stem cell‐derived intestinal organoids using natural polysaccharides. Biomaterials. 2022;288 :121696.36038421
112 Luo X , Fong ELS , Zhu C , et al. Hydrogel‐based colorectal cancer organoid co‐culture models. Acta Biomater. 2021;132 :461‐472.33388439
113 Lee GY , Kenny PA , Lee EH , Bissell MJ . Three‐dimensional culture models of normal and malignant breast epithelial cells. Nat Methods. 2007;4 (4 ):359‐365.17396127
114 Qi C , Li Y , Badger P , et al. Pathology‐targeted cell delivery via injectable micro‐scaffold capsule mediated by endogenous tgase. Biomaterials. 2017;126 :1‐9.28237907
115 Revah O , Gore F , Kelley KW , et al. Maturation and circuit integration of transplanted human cortical organoids. Nature. 2022;610 (7931 ):319‐326.36224417
116 Onion D , Argent RH , Reece‐Smith AM , et al. 3‐dimensional patient‐derived lung cancer assays reveal resistance to standards‐of‐care promoted by stromal cells but sensitivity to histone deacetylase inhibitors. Mol Cancer Ther. 2016;15 (4 ):753‐763.26873730
117 Weems AD , Welf ES , Driscoll MK , et al. Blebs promote cell survival by assembling oncogenic signalling hubs. Nature. 2023;615 (7952 ):517‐525.36859545
118 Han H , Sung JY , Kim S , et al. Fibronectin regulates anoikis resistance via cell aggregate formation. Cancer Lett. 2021;508 :59‐72.33771684
119 Nicklin M , Rees RC , Pockley AG , Perry CC . Development of an hydrophobic fluoro‐silica surface for studying homotypic cancer cell aggregation‐disaggregation as a single dynamic process in vitro. Biomater Sci. 2014;2 (10 ):1486‐1496.32481924
120 Yamanaka S . Induced pluripotent stem cells: past, present, and future. Cell Stem Cell. 2012;10 (6 ):678‐684.22704507
121 Lau KYC , Rubinstein H , Gantner CW , et al. Mouse embryo model derived exclusively from embryonic stem cells undergoes neurulation and heart development. Cell Stem Cell. 2022;29 (10 ):1445‐1458.36084657
122 Kim DH , Martin JT , Gullbrand SE , et al. Fabrication, maturation, and implantation of composite tissue‐engineered total discs formed from native and mesenchymal stem cell combinations. Acta Biomater. 2020;114 :53‐62.32505801
123 Kruta M , Sunshine MJ , Chua BA , et al. Hsf1 promotes hematopoietic stem cell fitness and proteostasis in response to ex vivo culture stress and aging. Cell Stem Cell. 2021;28 (11 ):1950‐1965.34388375
124 Zhang X , Cao D , Xu L , et al. Harnessing matrix stiffness to engineer a bone marrow niche for hematopoietic stem cell rejuvenation. Cell Stem Cell. 2023;30 (4 ):378‐395.37028404
125 Xu Y , Zhou J , Liu C , et al. Understanding the role of tissue‐specific decellularized spinal cord matrix hydrogel for neural stem/progenitor cell microenvironment reconstruction and spinal cord injury. Biomaterials. 2021;268 :120596.33341040
126 Allen DE , Donohue KC , Cadwell CR , et al. Fate mapping of neural stem cell niches reveals distinct origins of human cortical astrocytes. Science. 2022;376 (6600 ):1441‐1446.35587512
127 Yan L , Yang M , Guo H , et al. Single‐cell rna‐seq profiling of human preimplantation embryos and embryonic stem cells. Nat Struct Mol Biol. 2013;20 (9 ):1131‐1139.23934149
128 Simunovic M , Siggia ED , Brivanlou AH . In vitro attachment and symmetry breaking of a human embryo model assembled from primed embryonic stem cells. Cell Stem Cell. 2022;29 (6 ):962‐972.35659878
129 Wang X , Lin G , Martins‐Taylor K , Zeng H , Xu R . Inhibition of caspase‐mediated anoikis is critical for basic fibroblast growth factor‐sustained culture of human pluripotent stem cells. J Biol Chem. 2009;284 (49 ):34054‐34064.19828453
130 Krawetz RJ , Li X , Rancourt DE . Human embryonic stem cells: caught between a rock inhibitor and a hard place. Bioessays. 2009;31 (3 ):336‐343.19260014
131 Ohgushi M , Matsumura M , Eiraku M , et al. Molecular pathway and cell state responsible for dissociation‐induced apoptosis in human pluripotent stem cells. Cell Stem Cell. 2010;7 (2 ):225‐239.20682448
132 Szatmári‐Tóth M , Ilmarinen T , Mikhailova A , et al. Human embryonic stem cell‐derived retinal pigment epithelium‐role in dead cell clearance and inflammation. Int J Mol Sci. 2019;20 (4 ):926.30791639
133 Wagh V , Meganathan K , Jagtap S , et al. Effects of cryopreservation on the transcriptome of human embryonic stem cells after thawing and culturing. Stem Cell Rev Rep. 2011;7 (3 ):506‐517.21279480
134 Zhang T , Huang X , Liu S , et al. Determining the optimal stage for cryopreservation of human embryonic stem cell‐derived retinal pigment epithelial cells. Stem Cell Res Ther. 2022;13 (1 ):454.36064625
135 Cheng Y , Hsieh ML , Lin C , et al. Combined treatment of human induced pluripotent stem cell‐derived cardiomyocytes and endothelial cells regenerate the infarcted heart in mice and non‐human primates. Circulation. 2023;148 (18 ):1395‐1409.37732466
136 Kitahata S , Tanaka Y , Hori K , et al. Critical functionality effects from storage temperature on human induced pluripotent stem cell‐derived retinal pigment epithelium cell suspensions. Sci Rep. 2019;9 (1 ):2891.30814559
137 Gapinske L , Clark L , Caro‐Rivera LM , Bashir R . Cryopreservation alters tissue structure and improves differentiation of engineered skeletal muscle. Tissue Eng Part A. 2023;29 (21‐22 ):557‐568.37463097
138 Gao L , Nath SC , Jiao X , et al. Post‐passage rock inhibition induces cytoskeletal aberrations and apoptosis in human embryonic stem cells. Stem Cell Res. 2019;41 :101641.31710913
139 Bouchentouf M , Benabdallah BF , Rousseau J , Schwartz LM , Tremblay JP . Induction of anoikis following myoblast transplantation into scid mouse muscles requires the bit1 and fadd pathways. Am J Transplant. 2007;7 (6 ):1491‐1505.17511679
140 Frisco‐Cabanos HL , Watanabe M , Okumura N , et al. Synthetic molecules that protect cells from anoikis and their use in cell transplantation. Angew Chem Int Ed Engl. 2014;53 (42 ):11208‐11213.25196666
141 Li X , Liu X , Tan Y , Tran V , Zhang N , Wen X . Improve the viability of transplanted neural cells with appropriate sized neurospheres coated with mesenchymal stem cells. Med Hypotheses. 2012;79 (2 ):274‐277.22657917
142 Chen H , Pan L , Yang H , et al. Integrin alpha5beta1 suppresses rbmscs anoikis and promotes nitric oxide production. Biomed Pharmacother. 2018;99 :1‐8.29324307
143 Chan AT , Karakas MF , Vakrou S , et al. Hyaluronic acid‐serum hydrogels rapidly restore metabolism of encapsulated stem cells and promote engraftment. Biomaterials. 2015;73 :1‐11.26378976
144 Tan Y , Wang L , Chen G , et al. Hyaluronate supports hesc‐cardiomyocyte cell therapy for cardiac regeneration after acute myocardial infarction. Cell Prolif. 2020;53 (12 ):e12942.33107673
145 Watanabe H , Belyea BC , Paxton RL , et al. Renin cell baroreceptor, a nuclear mechanotransducer central for homeostasis. Circ Res. 2021;129 (2 ):262‐276.33993729
146 Lolo F , Pavón DM , Grande‐García A , et al. Caveolae couple mechanical stress to integrin recycling and activation. eLife. 2022;11 :e82348.36264062
147 Karoubi G , Ormiston ML , Stewart DJ , Courtman DW . Single‐cell hydrogel encapsulation for enhanced survival of human marrow stromal cells. Biomaterials. 2009;30 (29 ):5445‐5455.19595454
148 Bertheloot D , Latz E , Franklin BS . Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021;18 (5 ):1106‐1121.33785842
149 Mason JA , Cockfield JA , Pape DJ , et al. Sgk1 signaling promotes glucose metabolism and survival in extracellular matrix detached cells. Cell Rep. 2021;34 (11 ):108821.33730592
150 Ded L , Hwang JY , Miki K , Shi HF , Chung J . 3d in situ imaging of the female reproductive tract reveals molecular signatures of fertilizing spermatozoa in mice. eLife. 2020;9 :e62043.33078708
151 Shi J , Lai Z , Yang H , et al. Collagen at the maternal‐fetal interface in human pregnancy. Int J Biol Sci. 2020;16 (12 ):2220‐2234.32549767
152 Tachibana Y , Sakurai T , Bai H , et al. Rna‐seq analysis of equine conceptus transcripts during embryo fixation and capsule disappearance. PLoS One. 2014;9 (12 ):e114414.25514169
153 Wang S , Matsumoto K , Lish SR , Cartagena‐Rivera AX , Yamada KM . Budding epithelial morphogenesis driven by cell‐matrix versus cell‐cell adhesion. Cell. 2021;184 (14 ):3702‐3716.34133940
154 Pontzer H , Yamada Y , Sagayama H , et al. Daily energy expenditure through the human life course. Science. 2021;373 (6556 ):808‐812.34385400
155 Ferreira AC , Hemmer BM , Philippi SM , et al. Neuronal timp2 regulates hippocampus‐dependent plasticity and extracellular matrix complexity. Mol Psychiatry. 2023;28 (9 ):3943‐3954.37914840
156 Stearns‐Reider KM , D'Amore A , Beezhold K , et al. Aging of the skeletal muscle extracellular matrix drives a stem cell fibrogenic conversion. Aging Cell. 2017;16 (3 ):518‐528.28371268
157 László ZI , Lele Z , Zöldi M , et al. Abhd4‐dependent developmental anoikis safeguards the embryonic brain. Nat Commun. 2020;11 (1 ):4363.32868797
158 Humphreys RC , Krajewska M , Krnacik S , et al. Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development. 1996;122 (12 ):4013‐4022.9012521
159 Boudreau N , Sympson CJ , Werb Z , Bissell MJ . Suppression of ice and apoptosis in mammary epithelial cells by extracellular matrix. Science. 1995;267 (5199 ):891‐893.7531366
160 Toivanen R , Mohan A , Shen MM . Basal progenitors contribute to repair of the prostate epithelium following induced luminal anoikis. Stem Cell Rep. 2016;6 (5 ):660‐667.
161 Rayagiri SS , Ranaldi D , Raven A , et al. Basal lamina remodeling at the skeletal muscle stem cell niche mediates stem cell self‐renewal. Nat Commun. 2018;9 (1 ):1075.29540680
162 Chen J , Sun M , Chen C , et al. Construction of a novel anoikis‐related prognostic model and analysis of its correlation with infiltration of immune cells in neuroblastoma. Front Immunol. 2023;14 :1135617.37081871
163 Xu Z , Li Y , Li P , et al. Soft substrates promote direct chemical reprogramming of fibroblasts into neurons. Acta Biomater. 2022;152 :255‐272.36041647
164 Imamaki R , Ogawa K , Kizuka Y , et al. Glycosylation controls cooperative pecam‐vegfr2‐β3 integrin functions at the endothelial surface for tumor angiogenesis. Oncogene. 2018;37 (31 ):4287‐4299.29717262
165 Maes ME , Donahue RJ , Schlamp CL , Marola OJ , Libby RT , Nickells RW . Bax activation in mouse retinal ganglion cells occurs in two temporally and mechanistically distinct steps. Mol Neurodegener. 2023;18 (1 ):67.37752598
166 Yin J , Wang J , Zhang X , et al. A missing piece of the puzzle in pulmonary fibrosis: anoikis resistance promotes fibroblast activation. Cell Biosci. 2022;12 (1 ):21.35216634
167 Schaschkow A , Sigrist S , Mura C , et al. Glycaemic control in diabetic rats treated with islet transplantation using plasma combined with hydroxypropylmethyl cellulose hydrogel. Acta Biomater. 2020;102 :259‐272.31811957
168 Feng M , Ma M , Fu Y , et al. Elevated autocrine edil3 protects hepatocellular carcinoma from anoikis through rgd‐mediated integrin activation. Mol Cancer. 2014;13 :226.25273699
169 Dobler D , Ahmed N , Song L , Eboigbodin KE , Thornalley PJ . Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by rgd and gfoger motif modification. Diabetes. 2006;55 (7 ):1961‐1969.16804064
170 Michel J . Anoikis in the cardiovascular system: known and unknown extracellular mediators. Arterioscler Thromb Vasc Biol. 2003;23 (12 ):2146‐2154.14551156
171 Sater AP , Rael LT , Tanner AH , et al. Cell death after traumatic brain injury: detrimental role of anoikis in healing. Clin Chim Acta. 2018;482 :149‐154.29627488
172 Schonfeld M , Villar MT , Artigues A , Weinman SA , Tikhanovich I . Arginine methylation of integrin alpha‐4 prevents fibrosis development in alcohol‐associated liver disease. Cell Mol Gastroenterol Hepatol. 2023;15 (1 ):39‐59.36191854
173 Qin L , Chen Z , Yang D , et al. Osteocyte β3 integrin promotes bone mass accrual and force‐induced bone formation in mice. J Orthop Translat. 2023;40 :58‐71.37457310
174 Zhang H , Hughes CS , Li W , et al. Proteomic screens for suppressors of anoikis identify il1rap as a promising surface target in ewing sarcoma. Cancer Discov. 2021;11 (11 ):2884‐2903.34021002
175 Yu Y , Song Y , Cheng L , et al. Circcemip promotes anoikis‐resistance by enhancing protective autophagy in prostate cancer cells. J Exp Clin Cancer Res. 2022;41 (1 ):188.35655258
176 Zhou Z , Luo A , Shrivastava I , et al. Regulation of xiap turnover reveals a role for usp11 in promotion of tumorigenesis. Ebiomedicine. 2017;15 :48‐61.28040451
177 Lum E , Vigliotti M , Banerjee N , et al. Loss of dok2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis. Gynecol Oncol. 2013;130 (2 ):369‐376.23684582
178 Wang K , Yuen ST , Xu J , et al. Whole‐genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014;46 (6 ):573‐582.24816253
179 Zhu Y , Wu S , Yang S , et al. Identification and validation of a novel anoikis‐related signature for predicting prognosis and immune landscape in ovarian serous cystadenocarcinoma. Heliyon. 2023;9 (8 ):e18708.37554782
180 Zhou Y , Wang C , Chen Y , et al. A novel risk model based on anoikis: predicting prognosis and immune infiltration in cutaneous melanoma. Front Pharmacol. 2022;13 :1090857.36726781
181 Shi J , Peng B , Zhou X , et al. An anoikis‐based gene signature for predicting prognosis in malignant pleural mesothelioma and revealing immune infiltration. J Cancer Res Clin Oncol. 2023;149 (13 ):12089‐12102.37421452
182 Huang J , Zhang L , Wan D , et al. Extracellular matrix and its therapeutic potential for cancer treatment. Signal Transduct Target Ther. 2021;6 (1 ):153.33888679
183 Wang Y , Zeng Z , Lu J , et al. Cpt1a‐mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis. Oncogene. 2018;37 (46 ):6025‐6040.29995871
184 Ye G , Yang Q , Lei X , et al. Nuclear myh9‐induced ctnnb1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis. Theranostics. 2020;10 (17 ):7545‐7560.32685004
185 Yu Y , Liu B , Li X , et al. Atf4/cemip/pkcα promotes anoikis resistance by enhancing protective autophagy in prostate cancer cells. Cell Death Dis. 2022;13 (1 ):46.35013120
186 Yu S , Hu J , Kuang X , et al. Microrna‐200a promotes anoikis resistance and metastasis by targeting yap1 in human breast cancer. Clin Cancer Res. 2013;19 (6 ):1389‐1399.23340296
187 Tian T , Lu Y , Lin J , et al. Cpt1a promotes anoikis resistance in esophageal squamous cell carcinoma via redox homeostasis. Redox Biol. 2022;58 :102544.36427397
188 Du L , Han X , Tu B , et al. Cxcr1/akt signaling activation induced by mesenchymal stem cell‐derived il‐8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis. Cell Death Dis. 2018;9 (7 ):714.29915309
189 Huh HD , Sub Y , Oh J , et al. Reprogramming anchorage dependency by adherent‐to‐suspension transition promotes metastatic dissemination. Mol Cancer. 2023;22 (1 ):63.36991428
190 Fu A , Yao B , Dong T , et al. Tumor‐resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell. 2022;185 (8 ):1356‐1372.35395179
191 Tadić V , Zhang W , Brozovic A . The high‐grade serous ovarian cancer metastasis and chemoresistance in 3d models. Biochim Biophys Acta Rev Cancer. 2024;1879 (1 ):189052.38097143
192 Sun T , Zhang Z , Tian L , et al. Dualistic classification of high grade serous ovarian carcinoma has its root in spatial heterogeneity. J Adv Res. 2023;48 :213‐225.36038111
193 Izar B , Tirosh I , Stover EH , et al. A single‐cell landscape of high‐grade serous ovarian cancer. Nat Med. 2020;26 (8 ):1271‐1279.32572264
194 Li Y , Fei H , Lin Q , et al. Zeb2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem‐like cells in high‐grade serous ovarian cancers. Oncogene. 2021;40 (32 ):5131‐5141.34211089
195 Zink KE , Dean M , Burdette JE , Sanchez LM . Imaging mass spectrometry reveals crosstalk between the fallopian tube and the ovary that drives primary metastasis of ovarian cancer. Acs Cent Sci. 2018;4 (10 ):1360‐1370.30410974
196 Mei J , Tian H , Huang H , et al. Cellular models of development of ovarian high‐grade serous carcinoma: a review of cell of origin and mechanisms of carcinogenesis. Cell Prolif. 2021;54 (5 ):e13029.33768671
197 Wheeler LJ , Watson ZL , Qamar L , et al. Cbx2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer. Oncogenesis. 2018;7 (11 ):92.30478317
198 Wheeler LJ , Watson ZL , Qamar L , et al. Multi‐omic approaches identify metabolic and autophagy regulators important in ovarian cancer dissemination. iScience. 2019;19 :474‐491.31437751
199 Gao Q , Yang Z , Xu S , et al. Heterotypic caf‐tumor spheroids promote early peritoneal metastatis of ovarian cancer. J Exp Med. 2019;216 (3 ):688‐703.30710055
200 Yin M , Li X , Tan S , et al. Tumor‐associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. J Clin Invest. 2016;126 (11 ):4157‐4173.27721235
201 Yang J , Zhang Y , Cheng S , et al. Anoikis‐related signature predicts prognosis and characterizes immune landscape of ovarian cancer. Cancer Cell Int. 2024;24 (1 ):53.38310291
202 Duan Y , Xu X . A signature based on anoikis‐related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer. Front Endocrinol (Lausanne). 2023;14 :1193622.37383389
203 Que Z , Luo B , Yu P , et al. Polyphyllin vii induces ctc anoikis to inhibit lung cancer metastasis through egfr pathway regulation. Int J Biol Sci. 2023;19 (16 ):5204‐5217.37928267
204 Bose M , Sanders A , De C , et al. Targeting tumor‐associated muc1 overcomes anoikis‐resistance in pancreatic cancer. Transl Res. 2023;253 :41‐56.36031050
205 Li N , Jia X , Wang Z , et al. Characterization of anoikis‐based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling. Front Endocrinol (Lausanne). 2023;14 :1153909.37234801
206 Wang Y , Cheng S , Fleishman JS , et al. Targeting anoikis resistance as a strategy for cancer therapy. Drug Resist Updat. 2024;75 :101099.38850692
207 Park SH , Riley PT , Frisch SM . Regulation of anoikis by deleted in breast cancer‐1 (dbc1) through nf‐κb. Apoptosis. 2013;18 (8 ):949‐962.23588592
208 Kawai H , Kobayashi M , Hiramoto‐Yamaki N , Harada K , Negishi M , Katoh H . Ephexin4‐mediated promotion of cell migration and anoikis resistance is regulated by serine 897 phosphorylation of epha2. Febs Open Bio. 2013;3 :78‐82.
209 Luey BC , May FEB . Insulin‐like growth factors are essential to prevent anoikis in oestrogen‐responsive breast cancer cells: importance of the type i igf receptor and pi3‐kinase/akt pathway. Mol Cancer. 2016;15 :8.26801096
210 Wang L , Zhang Z , Wang L , et al. Tgf‐β1/sh2b3 axis regulates anoikis resistance and emt of lung cancer cells by modulating jak2/stat3 and shp2/grb2 signaling pathways. Cell Death Dis. 2022;13 (5 ):472.35589677
211 Byerly J , Halstead‐Nussloch G , Ito K , Katsyv I , Irie HY . Prkcq promotes oncogenic growth and anoikis resistance of a subset of triple‐negative breast cancer cells. Breast Cancer Res. 2016;18 (1 ):95.27663795
212 Li T , Yu Y , Song Y , et al. Activation of bdnf/trkb pathway promotes prostate cancer progression via induction of epithelial‐mesenchymal transition and anoikis resistance. FASEB J. 2020;34 (7 ):9087‐9101.32390303
213 Brown CW , Brodsky AS , Freiman RN . Notch3 overexpression promotes anoikis resistance in epithelial ovarian cancer via upregulation of col4a2. Mol Cancer Res. 2015;13 (1 ):78‐85.25169943
214 Hindupur SK , Balaji SA , Saxena M , et al. Identification of a novel ampk‐pea15 axis in the anoikis‐resistant growth of mammary cells. Breast Cancer Res. 2014;16 (4 ):420.25096718
215 Tan M , Asad M , Heong V , et al. The fzd7‐twist1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinoma. Mol Oncol. 2019;13 (4 ):757‐780.30548372
216 Doxtater K , Tripathi MK , Sekhri R , et al. Muc13 drives cancer aggressiveness and metastasis through the yap1‐dependent pathway. Life Sci Alliance. 2023;6 (12 ):e202301975.37793774
217 Derouet MF , Dakpo E , Wu L , et al. Mir‐145 expression enhances integrin expression in sk‐gt‐4 cell line by down‐regulating c‐myc expression. Oncotarget. 2018;9 (20 ):15198‐15207.29632636
218 Sun Q , Yang Z , Li P , et al. A novel mirna identified in grsf1 complex drives the metastasis via the pik3r3/akt/nf‐κb and timp3/mmp9 pathways in cervical cancer cells. Cell Death Dis. 2019;10 (9 ):636.31474757
219 Tian H , Lian R , Li Y , et al. Akt‐induced lncrna val promotes emt‐independent metastasis through diminishing trim16‐dependent vimentin degradation. Nat Commun. 2020;11 (1 ):5127.33046716
220 Song J , Liu Y , Liu F , et al. The 14‐3‐3σ protein promotes hcc anoikis resistance by inhibiting egfr degradation and thereby activating the egfr‐dependent erk1/2 signaling pathway. Theranostics. 2021;11 (3 ):996‐1015.33391517
221 Jang E , Sung JY , Yoo H , et al. Fam188b downregulation sensitizes lung cancer cells to anoikis via egfr downregulation and inhibits tumor metastasis in vivo. Cancers (Basel). 2021;13 (2 ):247.33440835
222 Netsirisawan P , Chaiyawat P , Chokchaichamnankit D , et al. Decreasing o‐glcnacylation affects the malignant transformation of mcf‐7 cells via hsp27 expression and its o‐glcnac modification. Oncol Rep. 2018;40 (4 ):2193‐2205.30106436
223 Piyush T , Rhodes JM , Yu L . Muc1 o‐glycosylation contributes to anoikis resistance in epithelial cancer cells. Cell Death Discov. 2017;3 :17044.28725490
224 Yao X , Pham T , Temple B , et al. Tle1 inhibits anoikis and promotes tumorigenicity in human lung cancer cells through zeb1‐mediated e‐cadherin repression. Oncotarget. 2017;8 (42 ):72235‐72249.29069783
225 Meng Q , Lu Y , Wei C , et al. Arginine methylation of mthfd1 by prmt5 enhances anoikis resistance and cancer metastasis. Oncogene. 2022;41 (32 ):3912‐3924.35798877
226 Dai Z , Jin S , Luo H , Leng H , Fang J . Lncrna hotair regulates anoikis‐resistance capacity and spheroid formation of ovarian cancer cells by recruiting ezh2 and influencing h3k27 methylation. Neoplasma. 2021;68 (3 ):509‐518.33502891
227 Wang S , Liu L , Bao K , et al. Ezh2 contributes to anoikis resistance and promotes epithelial ovarian cancer peritoneal metastasis by regulating m6a. Curr Med Sci. 2023;43 (4 ):794‐802.37498408
228 Wang L , Li C , Wang J , et al. Transformable ecm deprivation system effectively suppresses renal cell carcinoma by reversing anoikis resistance and increasing chemotherapy sensitivity. Adv Mater. 2022;34 (43 ):e2203518.36004775
229 Fonseca I , Horta C , Ribeiro AS , et al. Polo‐like kinase 4 (plk4) potentiates anoikis‐resistance of p53ko mammary epithelial cells by inducing a hybrid emt phenotype. Cell Death Dis. 2023;14 (2 ):133.36797240
230 Boese AC , Kang J , Hwang JS , et al. Succinyl‐coa ligase adp‐forming subunit beta promotes stress granule assembly to regulate redox and drive cancer metastasis. Proc Natl Acad Sci USA. 2023;120 (23 ):e2077635176.
231 Chen X , Xia Q , Sun N , et al. Shear stress enhances anoikis resistance of cancer cells through ros and no suppressed degeneration of caveolin‐1. Free Radical Biol Med. 2022;193 (1 ):95‐107. Pt.36243211
232 Dhillon S . Carotegrast methyl: first approval. Drugs. 2022;82 (9 ):1011‐1016.35723803
233 Talamonti M , Spallone G , Di Stefani A , Costanzo A , Chimenti S . Efalizumab. Expert Opin Drug Saf. 2011;10 (2 ):239‐251.21214420
234 Abramson J , Adler J , Dunger J , et al. Accurate structure prediction of biomolecular interactions with alphafold 3. Nature. 2024;630 (8016 ):493‐500.38718835
235 Wenta T , Schmidt A , Zhang Q , et al. Disassembly of α6β4‐mediated hemidesmosomal adhesions promotes tumorigenesis in pten‐negative prostate cancer by targeting plectin to focal adhesions. Oncogene. 2022;41 (30 ):3804‐3820.35773413
236 Tajbakhsh A , Rivandi M , Abedini S , Pasdar A , Sahebkar A . Regulators and mechanisms of anoikis in triple‐negative breast cancer (tnbc): a review. Crit Rev Oncol Hematol. 2019;140 :17‐27.31154235
237 Reavis HD , Gysler SM , Mckenney GB , et al. Norepinephrine induces anoikis resistance in high‐grade serous ovarian cancer precursor cells. Jci Insight. 2024;9 (5 ):e170961.38271085
238 Gong Z , Chen M , Ren Q , Yue X , Dai Z . Fibronectin‐targeted dual‐acting micelles for combination therapy of metastatic breast cancer. Signal Transduct Target Ther. 2020;5 (1 ):12.32296050
239 Sodek KL , Murphy KJ , Brown TJ , Ringuette MJ . Cell‐cell and cell‐matrix dynamics in intraperitoneal cancer metastasis. Cancer Metastasis Rev. 2012;31 (1‐2 ):397‐414.22527451
240 Liau S , Jazag A , Ito K , Whang EE . Overexpression of hmga1 promotes anoikis resistance and constitutive akt activation in pancreatic adenocarcinoma cells. Br J Cancer. 2007;96 (6 ):993‐1000.17342093
241 Dhawan P , Singh AB , Deane NG , et al. Claudin‐1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest. 2005;115 (7 ):1765‐1776.15965503
242 Singh AB , Sharma A , Dhawan P . Claudin‐1 expression confers resistance to anoikis in colon cancer cells in a src‐dependent manner. Carcinogenesis. 2012;33 (12 ):2538‐2547.22941059
243 Bhat AA , Ahmad R , Uppada SB , Singh AB , Dhawan P . Claudin‐1 promotes tnf‐α‐induced epithelial‐mesenchymal transition and migration in colorectal adenocarcinoma cells. Exp Cell Res. 2016;349 (1 ):119‐127.27742576
244 Primeaux M , Liu X , Gowrikumar S , et al. Claudin‐1 interacts with epha2 to promote cancer stemness and chemoresistance in colorectal cancer. Cancer Lett. 2023;579 :216479.37924938
245 Altschuler J , Stockert JA , Kyprianou N . Non‐coding rnas set a new phenotypic frontier in prostate cancer metastasis and resistance. Int J Mol Sci. 2021;22 (4 ):2100.33672595
246 Wade CA , Kyprianou N . Profiling prostate cancer therapeutic resistance. Int J Mol Sci. 2018;19 (3 ):904.29562686
247 Zhu C , Teng L , Lai Y , et al. Adipose‐derived stem cells promote glycolysis and peritoneal metastasis via tgf‐β1/smad3/angptl4 axis in colorectal cancer. Cell Mol Life Sci. 2024;81 (1 ):189.38643448
248 Heissig B , Salama Y , Osada T , Okumura K , Hattori K . The multifaceted role of plasminogen in cancer. Int J Mol Sci. 2021;22 (5 ):2304.33669052
249 Douma S , Van Laar T , Zevenhoven J , Meuwissen R , Van Garderen E , Peeper DS . Suppression of anoikis and induction of metastasis by the neurotrophic receptor trkb. Nature. 2004;430 (7003 ):1034‐1039.15329723
250 Kim MS , Lee WS , Jin W . Trkb inhibition of dj‐1 degradation promotes the growth and maintenance of cancer stem cell characteristics in hepatocellular carcinoma. Cell Mol Life Sci. 2023;80 (10 ):303.37749450
251 Liu T , Li K , Zhang Z , et al. Tetrandrine inhibits cancer stem cell characteristics and epithelial to mesenchymal transition in triple‐negative breast cancer via sod1/ros signaling pathway. Am J Chin Med. 2023;51 (2 ):425‐444.36692485
252 Thomas P , Pranatharthi A , Ross C , Srivastava S . Rhoc: a fascinating journey from a cytoskeletal organizer to a cancer stem cell therapeutic target. J Exp Clin Cancer Res. 2019;38 (1 ):328.31340863
253 Polanco A , Kuang B , Yoon S . Bioprocess technologies that preserve the quality of ipscs. Trends Biotechnol. 2020;38 (10 ):1128‐1140.32941792
254 Rodas‐Junco BA , Villicaña C . Dental pulp stem cells: current advances in isolation, expansion and preservation. Tissue Eng Regen Med. 2017;14 (4 ):333‐347.30603490
255 Baldari S , Di Rocco G , Piccoli M , Pozzobon M , Muraca M , Toietta G . Challenges and strategies for improving the regenerative effects of mesenchymal stromal cell‐based therapies. Int J Mol Sci. 2017;18 (10 ):2087.28974046
256 Jang S , Jeong JG , Oh TI , Lee E . Biomaterials for cell‐surface engineering and their efficacy. J Funct Biomater. 2021;12 (3 ):41.34287337
257 Newland B , Welzel PB , Newland H , et al. Tackling cell transplantation anoikis: an injectable, shape memory cryogel microcarrier platform material for stem cell and neuronal cell growth. Small (Weinheim an Der Bergstrasse, Germany). 2015;11 (38 ):5047‐5053.26237446
258 Zhang J , Tokatlian T , Zhong J , et al. Physically associated synthetic hydrogels with long‐term covalent stabilization for cell culture and stem cell transplantation. Adv Mater. 2011;23 (43 ):5098‐5103.21997799
259 Kerr JF , Wyllie AH , Currie AR . Apoptosis: a basic biological phenomenon with wide‐ranging implications in tissue kinetics. Br J Cancer. 1972;26 (4 ):239‐257.4561027
260 Wang L , Liu X , Li Q , et al. The romantic history of signaling pathway discovery in cell death: an updated review. Mol Cell Biochem. 2023.
261 Tian H , Mei J , Cao L , et al. Disruption of iron homeostasis to induce ferroptosis with albumin‐encapsulated pt(iv) nanodrug for the treatment of non‐small cell lung cancer. Small. 2023;19 (49 ):e2206688.37606911
262 Meng Y , Chen X , Deng G . Disulfidptosis: a new form of regulated cell death for cancer treatment. Mol Biomed. 2023;4 (1 ):18.37318660
263 Tsvetkov P , Coy S , Petrova B , et al. Copper induces cell death by targeting lipoylated tca cycle proteins. Science. 2022;375 (6586 ):1254‐1261.35298263
264 Tang T , Liang H , Wei W , et al. Aloperine targets lysosomes to inhibit late autophagy and induces cell death through apoptosis and paraptosis in glioblastoma. Mol Biomed. 2023;4 (1 ):42.37975957
265 Sega M , Chignola R . Population ecology of heterotypic tumour cell cultures. Cell Prolif. 2014;47 (5 ):476‐483.25159179
266 Linkous A , Balamatsias D , Snuderl M , et al. Modeling patient‐derived glioblastoma with cerebral organoids. Cell Rep. 2019;26 (12 ):3203‐3211.30893594
267 Platt RJ , Chen S , Zhou Y , et al. Crispr‐cas9 knockin mice for genome editing and cancer modeling. Cell. 2014;159 (2 ):440‐455.25263330
268 Lancaster MA , Renner M , Martin C , et al. Cerebral organoids model human brain development and microcephaly. Nature. 2013;501 (7467 ):373‐379.23995685
269 Mei J , Liu X , Tian H , et al. Tumour organoids and assembloids: patient‐derived cancer avatars for immunotherapy. Clin Transl Med. 2024;14 (4 ):e1656.38664597
270 Jensen C , Teng Y . Is it time to start transitioning from 2d to 3d cell culture? Front Mol Biosci. 2020;7 :33.32211418
271 Kim J , Kim HN , Lim K , et al. Synergistic effects of nanotopography and co‐culture with endothelial cells on osteogenesis of mesenchymal stem cells. Biomaterials. 2013;34 (30 ):7257‐7268.23834896
272 Haisler WL , Timm DM , Gage JA , Tseng H , Killian TC , Souza GR . Three‐dimensional cell culturing by magnetic levitation. Nat Protoc. 2013;8 (10 ):1940‐1949.24030442
273 Loessner D , Meinert C , Kaemmerer E , et al. Functionalization, preparation and use of cell‐laden gelatin methacryloyl‐based hydrogels as modular tissue culture platforms. Nat Protoc. 2016;11 (4 ):727‐746.26985572
274 Buchheit CL , Weigel KJ , Schafer ZT . Cancer cell survival during detachment from the ecm: multiple barriers to tumour progression. Nat Rev Cancer. 2014;14 (9 ):632‐641.25098270
275 Ren B , Yang J , Wang C , et al. High‐resolution hi‐c maps highlight multiscale 3d epigenome reprogramming during pancreatic cancer metastasis. J Hematol Oncol. 2021;14 (1 ):120.34348759
276 Okae H , Toh H , Sato T , et al. Derivation of human trophoblast stem cells. Cell Stem Cell. 2018;22 (1 ):50‐63.29249463
277 Yoshida H , Lareau CA , Ramirez RN , et al. The cis‐regulatory atlas of the mouse immune system. Cell. 2019;176 (4 ):897‐912.30686579
278 Guo Q , Chen X , Chen J , et al. Sting promotes senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the nf‐κb signaling pathway. Cell Death Dis. 2021;12 (1 ):13.33414452
279 Khan SU , Fatima K , Malik F . Understanding the cell survival mechanism of anoikis‐resistant cancer cells during different steps of metastasis. Clin Exp Metastasis. 2022;39 (5 ):715‐726.35829806
280 Cyganek L , Tiburcy M , Sekeres K , et al. Deep phenotyping of human induced pluripotent stem cell‐derived atrial and ventricular cardiomyocytes. Jci Insight. 2018;3 (12 ):e99941.29925689
281 Guzzo RM , Gibson J , Xu R , Lee FY , Drissi H . Efficient differentiation of human ipsc‐derived mesenchymal stem cells to chondroprogenitor cells. J Cell Biochem. 2013;114 (2 ):480‐490.22961870
282 Li Q , Lin H , Du Q , et al. Scalable and physiologically relevant microenvironments for human pluripotent stem cell expansion and differentiation. Biofabrication. 2018;10 (2 ):25006.
283 Kropp C , Massai D , Zweigerdt R . Progress and challenges in large‐scale expansion of human pluripotent stem cells. Process Biochem. 2017;59 :244‐254.
284 Srimasorn S , Kirsch M , Hallmeyer‐Ellgner S , Lindemann D , Storch A , Hermann A . Increased neuronal differentiation efficiency in high cell density‐derived induced pluripotent stem cells. Stem Cells Int. 2019;2019 :2018784.31871463
285 Saccardi R , Blanquer M , Boieri M , et al. Fully automated washing of cryopreserved peripheral blood stem cells (pbsc): results of a prospective, multicenter, clinical trial. Blood. 2012;120 (21 ):3164.23086620
286 Elling U , Wimmer RA , Leibbrandt A , et al. A reversible haploid mouse embryonic stem cell biobank resource for functional genomics. Nature. 2017;550 (7674 ):114‐118.28953874
287 Winkel A , Jaimes Y , Melzer C , et al. Cell culture media notably influence properties of human mesenchymal stroma/stem‐like cells from different tissues. Cytotherapy. 2020;22 (11 ):653‐668.32855067
288 Saha K , Mei Y , Reisterer CM , et al. Surface‐engineered substrates for improved human pluripotent stem cell culture under fully defined conditions. Proc Natl Acad Sci USA. 2011;108 (46 ):18714‐18719.22065768
289 Viswanathan P , Ondeck MG , Chirasatitsin S , et al. 3d surface topology guides stem cell adhesion and differentiation. Biomaterials. 2015;52 :140‐147.25818420
290 Ekerdt BL , Fuentes CM , Lei Y , et al. Thermoreversible hyaluronic acid‐pnipaam hydrogel systems for 3d stem cell culture. Adv Healthc Mater. 2018;7 (12 ):e1800225.29717823
291 Chen W , Villa‐Diaz LG , Sun Y , et al. Nanotopography influences adhesion, spreading, and self‐renewal of human embryonic stem cells. Acs Nano. 2012;6 (5 ):4094‐4103.22486594
292 Babaei‐Abraki S , Karamali F , Nasr‐Esfahani MH . Ferroptosis: the functions of nrf2 in human embryonic stem cells. Cell Signal. 2023;106 :110654.36906163
293 Dekkers MPJ , Barde Y . Developmental biology. Programmed cell death in neuronal development. Science. 2013;340 (6128 ):39‐41.23559240
294 Cai Y , Zhou H , Zhu Y , et al. Elimination of senescent cells by β‐galactosidase‐targeted prodrug attenuates inflammation and restores physical function in aged mice. Cell Res. 2020;30 (7 ):574‐589.32341413
295 Kruyt FAE , Schuringa JJ . Apoptosis and cancer stem cells: implications for apoptosis targeted therapy. Biochem Pharmacol. 2010;80 (4 ):423‐430.20394737
296 Sharma R , Gogoi G , Saikia S , et al. Bmp4 enhances anoikis resistance and chemoresistance of breast cancer cells through canonical bmp signaling. J Cell Commun Signal. 2022;16 (2 ):191‐205.34608584
297 Lim W , Choi JW , Song N , Cho C , Rhee YK , Hong H . Polysaccharide isolated from persimmon leaves (diospyros kaki thunb.) suppresses tgf‐β1‐induced epithelial‐to‐mesenchymal transition in a549 cells. Int J Biol Macromol. 2020;164 :3835‐3845.32835798
298 Pratelli G , Carlisi D , Di Liberto D , et al. Mcl1 inhibition overcomes the aggressiveness features of triple‐negative breast cancer mda‐mb‐231 cells. Int J Mol Sci. 2023;24 (13 ):11149.37446326
299 Lee H , Park S , Kim JB , Kim J , Kim H . Entrapped doxorubicin nanoparticles for the treatment of metastatic anoikis‐resistant cancer cells. Cancer Lett. 2013;332 (1 ):110‐119.23348696
300 Huerta CT , Ortiz YY , Li Y , et al. Novel gene‐modified mesenchymal stem cell therapy reverses impaired wound healing in ischemic limbs. Ann Surg. 2023;278 (3 ):383‐395.37334717
301 Huang D , Cao Y , Yang X , et al. A nanoformulation‐mediated multifunctional stem cell therapy with improved beta‐amyloid clearance and neural regeneration for alzheimer's disease. Adv Mater. 2021;33 (13 ):e2006357.33624894
302 Bagó JR , Pegna GJ , Okolie O , Hingtgen SD . Fibrin matrices enhance the transplant and efficacy of cytotoxic stem cell therapy for post‐surgical cancer. Biomaterials. 2016;84 :42‐53.26803410
303 Qu X , An G , Sui W , et al. Phase 1 study of c‐car088, a novel humanized anti‐bcma car t‐cell therapy in relapsed/refractory multiple myeloma. J Immunother Cancer. 2022;10 (9 ):e5145.
304 He J , Xiong X , Yang H , et al. Defined tumor antigen‐specific t cells potentiate personalized tcr‐t cell therapy and prediction of immunotherapy response. Cell Res. 2022;32 (6 ):530‐542.35165422
305 van den Berg JH , Heemskerk B , van Rooij N , et al. Tumor infiltrating lymphocytes (til) therapy in metastatic melanoma: boosting of neoantigen‐specific t cell reactivity and long‐term follow‐up. J Immunother Cancer. 2020;8 (2 ):e848.
306 Li X , Xu Z , Du W , et al. Aiolos promotes anchorage independence by silencing p66shc transcription in cancer cells. Cancer Cell. 2014;25 (5 ):575‐589.24823637
307 Hinrichsen F , Hamm J , Westermann M , et al. Microbial regulation of hexokinase 2 links mitochondrial metabolism and cell death in colitis. Cell Metab. 2021;33 (12 ):2355‐2366.34847376
